CN109321592A - The method for generating HPV18 L1 albumen with expressed by Hansenula yeast system - Google Patents
The method for generating HPV18 L1 albumen with expressed by Hansenula yeast system Download PDFInfo
- Publication number
- CN109321592A CN109321592A CN201811381504.7A CN201811381504A CN109321592A CN 109321592 A CN109321592 A CN 109321592A CN 201811381504 A CN201811381504 A CN 201811381504A CN 109321592 A CN109321592 A CN 109321592A
- Authority
- CN
- China
- Prior art keywords
- hpv18
- albumen
- hansenula yeast
- yeast cell
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The present invention relates to the methods for generating HPV18 L1 albumen with expressed by Hansenula yeast system.Specifically, the invention discloses the method for the recombination Hansenula yeast cell for generating expression HPV18 L1 albumen and the recombination Hansenula yeast cells generated by the method.The invention also discloses preparing the purposes in preventative vaccine using the method and generated HPV18 L1 albumen of the recombination Hansenula yeast cell generation HPV18 L1 albumen.
Description
The application be the applying date be on January 21st, 2012, application No. is 201210021524.X, entitled " use the Chinese
The divisional application of the application for a patent for invention of the method that inferior yeast expression system generates HPV18 L1 albumen ".
Invention field
The invention belongs to medical bioengineering technical field, the method for being related to generating HPV18 L1 albumen, more particularly to use
The method of expressed by Hansenula yeast system generation HPV18 L1 albumen.
Background technique
Human papilloma virus (human papillomavirus, HPV) is a kind of nonencapsulated closed loop double-stranded DNA virus,
Belong to papovaviridae polyomavirus subfamily, the main epithelium mucous membrane tissue for invading human body, and then induces various benign and pernicious
Preneoplastic lesions.
Having identified the different subtype HPV come at present is more than 200 kinds, and HPV infection has apparent tissue specificity, different
The HPV of type is different for the thermophilic tropism of skin with mucous membrane, can induce different papillary lesions, about more than 30 kinds of HPV types
It is not related with reproductive tract infection, wherein have more than 20 kinds it is related to tumour.The good pernicious difference of lesion is induced according to HPV, HPV can be big
Cause is divided into two classes: 1) high-risk-type (such as HPV16, HPV18, HPV45, HPV31, HPV33, HPV52, HPV58, HPV35, HPV59,
HPV56, HPV39, HPV51 etc.): it is closely related with mankind's Various Tissues malignant tumour, mainly cause severe atypical hyperplasia and
Infiltrating carcinoma, especially the closest with the generation of cervical carcinoma with the infection of HPV16 and HPV18 type, the infection of the two types accounts for cervical carcinoma
70% or more of infection, wherein HPV16 accounts for 50% or more;2) low risk (such as HPV6, HPV11, HPV40, HPV42, HPV43,
HPV44, HPV54, HPV72, HPV 81 etc.): epidermal cell benign proliferative venereal disease can be caused, such as condyloma acuminatum and condyloma
Deng wherein accounting for 90% or more by the condyloma acuminatum that HPV6 and HPV11 induces.
HPV is mainly made of virus coat and genomic DNA.Genome is about 7900bp, there is 8 encoding hiv protease bases
Cause.Wherein the albumen of 6 ORF coding is in the early expression of virus replication, referred to as early protein;The albumen of 2 ORF coding is in disease
The advanced stage expression of poison duplication, referred to as late protein.Late protein includes major cat protein L1 and secondary coat protein L2, and is joined
With the formation of virus coat.
HPV viruse coat protein is able to carry out self assembly, the L1 albumen of single expression or by L1 in a variety of expression systems
Albumen and L2 albumen can be self-assembled into virus-like particle (virus-like particle, VLP) when co-expressing, wherein with
The VLP of the generations such as Yeast system, Baculovirus insect expression system and mammalian cell expression system is closer to natural viral
Structure.Generation neutralizing antibody can be induced in vivo after being immunized using the VLP of heterogenous expression system production, obtain good exempts from
Epidemic disease protecting effect.
Multiple-shaped nuohan inferior yeast (Hansenula Polymorpha), also referred to as Pichia augusta are currently generally acknowledged
One of ideal heterologous gene expression system.It is raw both to have protokaryon as single celled eukaryotic microorganism for multiple-shaped nuohan inferior yeast
Object fast growing is easy to the features such as genetic manipulation, and has the functions such as eukaryocyte post translational processing and modification.In addition, the inferior ferment of the Chinese
Mother is also equipped with that safety is good, be easy to cultivate, low in cost, expression quantity is high and the advantages such as inheritance stability, and can overcome such as
Saccharomyces cerevisiae (Saccharomyces cerevisiae) bacterial strain is unstable, low output and glycosylation side chain are too long and finish red ferment
The lower problem of female (Pichia Pastoris) exogenous origin gene integrator copy number.Currently, using expressed by Hansenula yeast system production
Drug (such as insulin, trade name Wosulin) and HBV vaccine (trade name Hepavax-Gene) list marketing.
Summary of the invention
In the first aspect, the present invention provides a kind of recombination Hansenula yeast cells for generating expression HPV18 L1 albumen
Method, it includes following steps:
A) by will include to encode the exogenous polynucleotide of the nucleotide sequence of HPV18 L1 albumen to be inserted into carrier and construct
Expression construct;
B) Hansenula yeast cell is converted with the expression construct obtained in step a);
C) the Hansenula yeast cell obtained in step b) is screened, obtains the recombination for containing the exogenous polynucleotide
Hansenula yeast cell.
In the second aspect, the present invention also provides the recombination Hansenula yeast cells generated according to the above method.
In the third aspect, the present invention also provides a kind of methods for generating HPV18 L1 albumen, comprising the following steps:
I) recombination Hansenula yeast cell of the invention is cultivated under conditions of being suitable for HPV18 L1 protein expression;
Ii it) is recycled from culture and purifies HPV18 L1 albumen.
In terms of the last one, the present invention also provides the HPV18 L1 albumen generated according to the method for the present invention to prepare
The purposes in vaccine for preventing HPV18 infection.
Detailed description of the invention
Fig. 1 in Hansenula yeast for expressing the carrier pRMHP2.1 structural schematic diagram of foreign protein.
Fig. 2A is using MOX promoter fragment as the Southern trace testing result of probe.With ATCC26012 genomic DNA
For control.1: control (applied sample amount are as follows: 1000ng);2: control (applied sample amount are as follows: 500ng);3: control (applied sample amount are as follows: 250ng);
4: control (applied sample amount are as follows: 125ng);5:HP/pRMHP2.1-18wt genomic DNA (applied sample amount are as follows: 7.8125ng, brightness are situated between
Between 500ng and 1000ng control);6:HP/pRMHP2.1-18sc genomic DNA (applied sample amount are as follows: 7.8125ng, brightness
Between 500ng and 1000ng control);7:HP/pRMHP2.1-18pp genomic DNA (applied sample amount are as follows: 7.8125ng, it is bright
Degree is between 250ng and 500ng control);8:HP/pRMHP2.1-18hp genomic DNA (applied sample amount are as follows: 7.8125ng,
Brightness is between 250ng and 500ng control);9:HP/pRMHP2.1-18hp-1 genomic DNA (applied sample amount are as follows: 62.5ng,
Its brightness is between 500ng and 1000ng control).
Fig. 2 B is using the genetic fragment of HPV18 L1 as the Southern trace testing result of probe.1:HP/pRMHP2.1-
18hp genomic DNA (applied sample amount are as follows: 16ng);2:HP/pRMHP2.1-18hp genomic DNA (applied sample amount are as follows: 8ng);3:HP/
PRMHP2.1-18hp genomic DNA (applied sample amount are as follows: 4ng);4:HP/pRMHP2.1-18hp genomic DNA (applied sample amount are as follows:
2ng);5:HP/pRMHP2.1-FMD18hp genomic DNA (applied sample amount are as follows: 8ng, HP/pRMHP2.1- of the brightness with 8ng
18hp genomic DNA);6:HP/pRMHP2.1-FMD18hp genomic DNA (applied sample amount are as follows: 4ng, HP/ of the brightness with 4ng
PRMHP2.1-18hp genomic DNA).
The SDS-PAGE result of Fig. 3 A HPV18 L1 albumen inducing expression in Escherichia coli.1: the control sample not induced
Product;2 and 3:IPTG inducing expression sample;4: protein marker.
The purification result of the HPV18 L1 albumen of Fig. 3 B prokaryotic expression.1: protein marker;2: upper prop sample;3: flowing through
Liquid;4: elution HPV18 L1 albumen.
Fig. 3 C rabbit polyclonal antibody prepares and purifies result.1: antiserum;2: flowing through liquid;3: antibody elution;4: albumen mark
Will object.
The western blot detection of Fig. 4 different recombination Hansenula yeast cellular expression levels.1:HP/pRMHP2.1-
18wt;2:HP/pRMHP2.1-18sc;3:HP/pRMHP2.1-18hp-1 (optimizes, exogenous origin gene integrator is copied for Hansenula yeast
Shellfish number is less than 15);4:HP/pRMHP2.1-18pp;5:HP/pRMHP2.1-18hp (optimizes for Hansenula yeast, integrates copy number
Greater than 31);6:HP/pRMHP2.1-FMD18hp (optimizes, integrate copy number greater than 31, FMD promoter) for Hansenula yeast;7:
Standard items (30 μ g/L);8: pre-dyed protein marker.
The detection of expression of HPV18 L1 albumen in Fig. 5 fermentation process.1: standard items (30 μ g/L);2: pre-dyed protein markers
Object;3: first 2 hours of induction;4: induction 0 hour;5: induction 2 hours;6: induction 4 hours;7: induction 8 hours;8: induction 10 is small
When.
The POROS 50HS of Fig. 6 A HPV18 L1 albumen purifies electrophoretogram.1: protein marker;2: upper prop sample;3: stream
Wear liquid;4~7: different NaCl concentration elutions.
The CHT of Fig. 6 B HPV18 L1 albumen purifies electrophoretogram.1: protein marker;2: upper prop sample;3: flowing through liquid;4~
8: different phosphate concn elutions.
The transmission electron microscope observing result of the HPV18 L1 albumen of Fig. 7 purifying.
Detailed description of the invention
U.S. Patent application US5,840,306 disclose expression of the HPV18 L1 albumen in saccharomyces cerevisiae, Chinese patent
Application CN101487010 discloses expression of the HPV18 L1 albumen in Pichia pastoris, but utilizes expressed by Hansenula yeast HPV18
L1 albumen is there is not yet open report.The present inventor has been successfully set up the method for generating HPV18 L1 albumen using Hansenula yeast,
Generated HPV18 L1 albumen can be self-assembled into virus-like particle, can be used for preparing the vaccine of prevention HPV infection.
Present invention firstly provides a kind of method of recombination Hansenula yeast cell for generating expression HPV18 L1 albumen, packets
Containing following steps:
A) by will include to encode the exogenous polynucleotide of the nucleotide sequence of HPV18 L1 albumen to be inserted into carrier and construct
Expression construct;
B) Hansenula yeast cell is converted with the expression construct obtained in step a);
C) the Hansenula yeast cell obtained in step b) is screened, obtains the recombination for containing the exogenous polynucleotide
Hansenula yeast cell.
The invention also includes the recombination Hansenula yeast cells generated according to the method.
Amino acid sequence from the HPV18 L1 albumen of different HPV18 Strain can have differences.The present inventor is logical
It crosses and HPV18 L1 protein sequence all in database is compared, chosen on each amino acid position of HPV18 L1 albumen
The highest amino acid residue of the frequency of occurrences, obtains the amino acid sequence for being shown in SEQ ID NO:1, which is HPV18 L1 egg
White most representative consensus sequence.Therefore, the HPV18 L1 albumen in the present invention preferably has ammonia shown in SEQ ID NO:1
Base acid sequence.
In order to efficiently express HPV18 L1 albumen, inventor's ammonia according to shown in SEQ ID NO:1 using Hansenula yeast
Base acid sequence carries out the codon optimization of nucleotide sequence for Hansenula yeast.Optimization principles include: a) to lose according to Hansenula yeast
Do you pass password frequency of use table (http://www.kazusa.or.jp/codon/cgi-bin/showcodon.cgi? species
=4905) frequency of use highest or higher codon are selected;B) avoid having potential impact to genetic transcription or protein translation
Negative regulatory element, such as the area PolyAT, the area PolyGC, the silencer area (Sliencer) and internal splice site;C) to including 5 '
It holds the mRNA secondary structure including the code area UTR, HPV18L1 and 3 ' end UTR to carry out comprehensive analysis, avoids complicated RNA second level knot
The formation of structure reduces the free energy of mRNA secondary structure;D) it is used as far as possible and Hansenula yeast promoter in upstream of coding region
The completely the same area 5'UTR of downstream native sequences;E) common restriction enzyme enzyme recognition site is eliminated.By the nucleosides of optimization
Acid sequence is shown in SEQ ID NO:5.It is preferably SEQ that the nucleotide sequence of HPV18 L1 albumen is encoded used in the present invention
Sequence shown in ID NO:5.
The present invention also provides a kind of new carriers in order to design and construct in expressed by Hansenula yeast foreign protein
PRMHP2.1, structure is as shown in Figure 1, sequence is shown in SEQ ID NO:6.By that will include the nucleosides for encoding HPV18 L1 albumen
The exogenous polynucleotide of acid sequence is cloned into pRMHP2.1 carrier, and expression construct of the invention can be obtained.Art technology
Personnel are it is to be appreciated that expression construct of the invention can also use other vector constructions, such as the Chinese patent authorized
Carrier described in CN100400665C.
In order to be expressed in Hansenula yeast, exogenous polynucleotide in the expression construct operably with promoter
It is connected with terminator.
As used herein, the function connects for referring at least two polynucleotides " are operably connected ".For example, operably connecting
It connects including the connection between promoter and another polynucleotides, wherein the promoter sequence originates and mediates this another is more
The transcription of nucleotide.Operably connection includes the connection between terminator and another polynucleotides, wherein the terminator
Terminate the transcription of another polynucleotides.
Being suitable for the invention promoter includes but is not limited to MOX, FMD, AOX1 and DHAS promoter.In some embodiment party
In case, promoter used in the present invention is the MOX promoter from Hansenula yeast.In other embodiments, of the invention
Used in promoter be the FMD promoter from Hansenula yeast.Being suitable for the invention terminator includes but is not limited to come from
The MOX terminator of Hansenula yeast.
Expression construct is converted to Hansenula yeast cell can be carried out with a variety of methods known in the art, including but not
It is limited to the conversion that electroporation and PEG are mediated.
In addition, developed in this field it is a variety of for expressing foreign protein Hansenula yeast bacterial strain, including but not limited to
CGMCC2.2498 Hansenula yeast, ATCC34438 Hansenula yeast and ATCC26012 Hansenula yeast cell.These Hansenula yeast bacterial strains
Also it can be applied to the present invention.In some embodiments, for converting the Hansenula yeast cell of expression construct of the invention
It is ATCC26012 Hansenula yeast cell.
In post-conversion, recombination Hansenula yeast cell can be selected according to the resistant gene carried on carrier.It is suitable anti-
Property gene includes but is not limited to Kan resistant gene and Zeocin resistant gene.According to used carrier, it is also possible to use nutrition
Defect culture medium recombinates Hansenula yeast cell to screen.
Expression and its copy number in Hansenula yeast of the exogenous polynucleotide in Hansenula yeast are positively correlated.Cause
This, further screening can also be carried out by the methods of Southern trace or quantitative PCR and contains multicopy external source multicore glycosides
The recombination Hansenula yeast cell of acid.It is preferred that exogenous polynucleotide copy number is greater than 5 recombination Hansenula yeast cell, more preferable external source
Polynucleotide copies number is greater than 30 recombination Hansenula yeast cell.
On the other hand, the present invention also provides a kind of methods for generating HPV18 L1 albumen, comprising the following steps:
I) recombination Hansenula yeast cell of the invention is cultivated under conditions of being suitable for HPV18 L1 protein expression;
Ii it) is recycled from culture and purifies HPV18 L1 albumen.
The various culture mediums and basic condition of culture known in the art that can be used for cultivating Hansenula yeast, those skilled in the art
It can be selected or be modified as needed.The culture of recombination expressed by Hansenula yeast bacterial strain of the invention can according to required protein content
To carry out in flask or be carried out in the bioreactor (fermentor of such as 30L) of different scales.It, can according to selected promoter
With the expression for suitable inducer being added in culture to induce the HPV18 L1 albumen.Using MOX or FMD promoter
In the case of, methanol is added as inducer.
Various protein purification modes known in the art, such as salt can be used in the purifying of generated HPV18 L1 albumen
The combination of analysis, ultrafiltration, precipitating, chromatography etc. or these modes.In one embodiment, chromatography media POROS 50HS is used first
(Applied Biosystems) carries out preliminary purification, followed by chromatography media Macro-Prep ceramic hydroxyapatite
(Type II, 40 μm) is further purified.
The HPV18 L1 albumen of the purifying prepared using method of the invention can be self-assembled into virus-like particle (embodiment
10, Fig. 7) good immunogenicity (embodiment 11), and in mouse is shown, therefore present invention provides the HPV18
L1 albumen is in preparation for preventing the purposes in the vaccine that HPV18 infects.
Embodiment
The present invention will be further illustrated by way of embodiment below, but is not therefore limited the present invention to described
Scope of embodiments in.
The analysis of embodiment 1:HPV18 L1 albumen consensus amino acid sequences
The HPV18 L1 albumen of overall length is made of 568 amino acid, and N-terminal lacks the truncated-type HPV18 of 61 amino acid
L1 albumen (containing 507 amino acid) is applied in preventative vaccine.It is retrieved by GenBank, obtains contain 507 altogether
HPV18L1 protein sequence 34 of 568 amino acid of a amino acid or overall length.Using Vector NTI software AlignX function into
The analysis of row amino acid alignment, obtains most representative HPV18 L1 consensus amino acid sequences (consensus amino
Acid sequence is all made of the sequence of the highest amino acid residue of probability of occurrence in each amino acid position of HPV18 L1
Column), sequence is as shown in SEQ ID NO:1.
Embodiment 2:HPV18 L1 encoding gene it is artificial synthesized
The present invention has synthesized 4 kinds of different HPV18 L1 nucleotide sequences altogether, be referred to as 18wt, 18sc, 18pp and
18hp:
1) 18wt- nucleosides identical with natural HPV18 L1 gene order shown in GenBank accession number ACU01871.1
Acid sequence is shown in SEQ ID NO:2;
2) 18sc- derives from U.S. Patent application US5, and the nucleotide sequence of 840,306 HPV18 L1 gene is shown in
SEQ ID NO:3;
3) 18pp- is shown in from the nucleotide sequence of the HPV18 L1 gene of Chinese patent application CN101487010
SEQ ID NO:4;
4) 18hp- the present inventor amino acid sequence according to shown in SEQ ID NO:1, it is inclined for Hansenula yeast genetic code
The nucleotide sequence of love property brand-new design, sequence are shown in SEQ ID NO:5.
According to the above nucleotide sequence, entrust Sinogenomax Co., Ltd. carry out respectively 18wt,
The complete sequence of 18sc, 18pp and 18hp are artificial synthesized, are cloned in carrier T and (are respectively designated as T-18wt, T-18sc, T-18pp
And T-18hp), and sequence verification is carried out to it.
The building of embodiment 3:pRMHP2.1 carrier
The present inventor designs and constructs the Hansenula yeast plasmid vector for being suitable for expressing foreign protein in Hansenula yeast
PRMHP2.1, structure are as shown in Figure 1.
The plasmid construction process is as follows:
(1) building carries the skeleton carrier pKO of Kan tolerant gene expression box and ColE1 duplication sub-district
With pPIC3.5K plasmid (Invitrogen company) for template, expanding acquisition size with primer 2 with primer 1 is
The ColE1 of 888bp replicates sub-district, while introducing BglIII restriction enzyme site in upstream, and downstream introduces KpnI restriction enzyme site;
Primer 1:5 '-GAagatctTACGGTTATCCACAGAATCAGG-3 ' (SEQ ID NO:7)
Primer 2: 5'-GGGGTACCTAAGCATTGGTAACTGTCAGAC-3 ' (SEQ ID NO:8)
With plasmid pPIC3.5K (Invitrogen company) for template, expanding acquisition size with primer 4 with primer 3 is
The Kan tolerant gene expression box of 1217bp, the Kan resistant gene derive from transposons Tn903, anti-card are showed in Escherichia coli
That chloramphenicol resistance shows anti-G418 resistance in yeast, introduces while expanding the Kan tolerant gene expression box in upstream
BglII restriction enzyme site, downstream introduce KpnI restriction enzyme site;
Primer 3:5'-GAagatctGAAAGCCACGTTGTGTCTCAAAATC-3 ' (SEQ ID NO:9)
Primer 4:5 '-GGGGTACCcctcgtgaagaaggtgttgctg-3 ' (SEQ ID NO:10)
Kan tolerant gene expression box and ColE1 are replicated sub-district by BglII+KpnI double digestion to be attached, construct bone
Frame carrier pKO.
(2) building of the PCR amplification of Zeocin resistance expression box and recombinant vector pKO-Zeo
Using the mixed genomic DNA of Hansenula yeast strains A TCC26012 and ATCC34438 as template, with primer 5 and primer
6 amplifications obtain the GADPH promoter region that size is 609bp, while introducing BglII and NotI restriction enzyme site in upstream;
Primer 5:5 '-GAagatctAAGGAAAAAAGCGGCCGCGTTGGTCTAGACTACATCCGTGCAC-3 ' (SEQ
ID NO:11)
Primer 6:5'-ATTGTTTCTATATTATCTTTGTAC-3 ' (SEQ ID NO:12)
Using the mixed genomic DNA of Hansenula yeast strains A TCC26012 and ATCC34438 as template, with primer 7 and primer
8 amplifications obtain the GADPH terminator district that size is 234bp, while introducing BamHI, EcoRV, PstI and EcoRI digestion in downstream
Site;
Primer 7:5'-GCACGGCCTCATCTACATATTTACG-3 ' (SEQ ID NO:13)
Primer 8:5 '-CGGGATCCGATATCctatcctgcagaaaagaattcGGACCACAATCCAAATAAAGA AAG-
3 ' (SEQ ID NO:14)
With pPICZ α plasmid (Invitrogen company) for template, obtaining size with primer 9 and the amplification of primer 10 is 424bp
Zeocin resistant gene, while introducing the overlap that GADPH promoter region 3 ' is held in upstream, it is whole to introduce GADPH in downstream
The only overlay region at 5 ' end of son;
Primer 9:5'-TAGTACAAAGATAATATAGAAACAATATGGCCAAGTTGACCAGTG-3 ' (SEQ ID NO:
15)
Primer 10:5'-TAAATATGTAGATGAGGCCGTGCTCAGTCCTGCTCCTCGGC-3 ' (SEQ ID NO:16)
It is with 3 segments (GAPDH promoter region, Zeocin resistant gene and GAPDH terminator district) of above-mentioned PCR amplification
Template obtains size with primer 5 and the amplification of primer 8 as the Zeocin tolerant gene expression box of 1218bp, while carrying in upstream
BglII and NotI restriction enzyme site carries BamHI, EcoRV, PstI and EcoRI restriction enzyme site in downstream.
By BglII+BamHI double digestion Zeocin tolerant gene expression box, and with BglII single endonuclease digestion and after dephosphorylation
PKO carrier be attached, construction recombination plasmid pKO-Zeo.
(3) building of the PCR amplification of HARS1 segment and recombinant vector pRMHP1.1
Using the mixed genomic DNA of Hansenula yeast strains A TCC26012 and ATCC34438 as template, with primer 11 with draw
The amplification of object 12 obtains the HARS1 segment that size is 544bp, while introducing PstI restriction enzyme site in upstream, introduces in downstream
EcoRI, SacI and NdeI restriction enzyme site;
Primer 11:5'-aaaactgcagGtcgactcccgcgactcggcgttcactttc-3 ' (SEQ ID NO:17)
Primer 12:5'-GGaattcTAGGGAGCTCccaattccatatgtcgacAAACCCGCGTTTGAG AACTTGC
TC-3 ' (SEQ ID NO:18)
HARS1 segment is cloned into pKO-Zeo carrier by EcoRI+PstI double digestion, constructs recombinant vector
pRMHP1.1。
(4) building of the PCR amplification of 18S rDNA sequence and recombinant vector pRMHP2.1
Using the mixed genomic DNA of Hansenula yeast strains A TCC26012 and ATCC34438 as template, with primer 13 with draw
The amplification of object 14 obtains the 18S rDNA sequence that size is 2.4Kb, while introducing NdeI restriction enzyme site in upstream, introduces in downstream
EcoRI restriction enzyme site;
Primer 13:5'-ggaattccatatgGGGTTTAGACCGTCGTGAGACAGG-3 ' (SEQ ID NO:19)
Primer 14:5'-ggaattcTTGCCATAGGCTAGTAATCC-3 ' (SEQ ID NO:20)
18S rDNA segment is cloned into pRMHP1.1 carrier by EcoRI+NdeI double digestion, constructs recombinant vector
pRMHP2.1。
Polymorpha expression vector pRMHP2.1 nucleotides sequence constructed by the present invention is shown in SEQ ID NO:6, Fig. 1 and is
Its structural schematic diagram.
Embodiment 4: generating expression construct (1) the MOX promoter for carrying different HPV18 L1 nucleotide sequences and MOX is whole
Only sub PCR amplification
Using the mixed genomic DNA of Hansenula yeast strains A TCC26012 and ATCC34438 as template, with primer 15 with draw
The amplification of object 16 obtains the MOX promoter that size is 1518bp, while introducing NotI restriction enzyme site in upstream;
Primer 15:5'-AAGGAAAAAAGCGGCCGCAACGATCTCCTCGAGCTGCTCGC-3 ' (SEQ ID NO:21)
Primer 16:5'-TTTGTTTTTGTACTTTAGATTGATGTC-3 ' (SEQ ID NO:22)
Using the mixed genomic DNA of Hansenula yeast strains A TCC26012 and ATCC34438 as template, with primer 17 with draw
The amplification of object 18 obtains the MOX terminator that size is 311bp, while introducing BglII restriction enzyme site in downstream;
Primer 17:5'-GGAGACGTGGAAGGACATACCGC-3 ' (SEQ ID NO:23)
Primer 18:5 '-GAagatctCAATCTCCGGAATGGTGATCTG-3 ' (SEQ ID NO:24)
(2) expression construct for carrying different HPV18 L1 nucleotide sequences is generated
To carry the recombinant plasmid T-18wt of 18wt as template, obtaining size with primer 19 and the amplification of primer 20 is 1572bp
HPV18 L1 gene, while upstream introduce MOX promoter region 3 ' hold overlap, downstream introduce MOX terminator 5 '
The overlay region at end;
Primer 19:5'-CATCAATCTAAAGTACAAAAACAAAATGGCTTTGTGGCGGCCTAGTGACA -3 ' (SEQ
ID NO:25)
Primer 2 0:5 '-GCGGTATGTCCTTCCACGTCTCCTTACTTCCTGGCACGTACACGCACA-3 ' (SEQ ID
NO:26)
To carry the recombinant plasmid T-18sc of 18sc as template, obtaining size with primer 21 and the amplification of primer 22 is 1572bp
HPV18 L1 gene, while upstream introduce MOX promoter region 3 ' hold overlap, downstream introduce MOX terminator 5 '
The overlay region at end;
3 ' (SEQ of primer 2 1:5'-CATCAATCTAAAGTACAAAAACAAAATGGCTTTGTGGCGGCCTAGTGACA-
ID NO:27)
Primer 2 2:5'-GCGGTATGTCCTTCCACGTCTCCTTACTTCCTGGCACGTACACGCACA-3 ' (SEQ ID
NO:28)
Using the recombinant plasmid T-18pp for carrying 18pp as template, it is primer with primer 23 and primer 24, expands and obtain size
For the HPV18 L1 gene of 1572bp, while the overlap that MOX promoter region 3 ' is held is introduced in upstream, introduces MOX in downstream
The overlay region that terminator 5 ' is held;
3 ' (SEQ of primer 2 3:5'-CATCAATCTAAAGTACAAAAACAAAATGGCTTTGTGGAGACCTTCTGACA-
ID NO:29)
Primer 2 4:5'-GCGGTATGTCCTTCCACGTCTCCTTACTTTCTAGCTCTAACTCTAACT-3 ' (SEQ ID
NO:30)
Using the recombinant plasmid T-18hp for carrying 18hp as template, it is primer with primer 25 and primer 26, expands and obtain size
For the HPV18 L1 gene of 1572bp, while the overlap that MOX promoter region 3 ' is held is introduced in upstream, introduces MOX in downstream
The overlay region that terminator 5 ' is held;
Primer 2 5:5 '-CATCAATCTAAAGTACAAAAACAAAATGGCTTTGTGGAGACCATCAGACA-3 ' (SEQ
ID NO:31)
Primer 2 6:5'-GCGGTATGTCCTTCCACGTCTCCTTACTTGCGAGCTCTGACCCTCACT-3 ' (SEQ ID
NO:32)
Respectively with above-mentioned PCR amplification obtain 3 segments (MOX promoter, 18wt gene/18sc gene/18pp gene/
18hp gene, MOX terminator) be template, with primer 15 and primer 18 amplification obtain size for 3.4Kb 18wt expression cassette/
18sc expression cassette/18pp expression cassette/18hp expression cassette, while NotI restriction enzyme site is carried in upstream, BglII enzyme is carried in downstream
Enzyme site.
18wt expression cassette, 18sc expression cassette, 18pp expression cassette and 18hp are expressed respectively by NotI+BglII double digestion
Box is cloned into pRMHP2.1 carrier, obtains expression construct pRMHP2.1-18wt, pRMHP2.1-18sc, pRMHP2.1-
18pp and pRMHP2.1-18hp.
(3) generation of the HPV18 L1 construct of FMD promoter is carried
Using the mixed genomic DNA of Hansenula yeast strains A TCC26012 and ATCC34438 as template, with primer 27 with draw
The amplification of object 28 obtains the FMD promoter region that size is 1115bp, while introducing NotI restriction enzyme site in upstream, introduces in downstream
Hp18 gene 5 ' end overlay region;
Primer 2 7:5 '-ATAAGAATGCGGCCGCGGATCCAGGAAGCGCAACGACG-3 ' (SEQ ID NO:33)
Primer 2 8:5 '-TGTCTGATGGTCTCCACAAAGCCATGATTTGATTGATGAAGGCAGAG-3 ' (SEQ ID
NO:34)
Using recombinant plasmid pRMHP2.1-18hp as template, obtaining size with primer 29 and the amplification of primer 30 is 1835bp's
18hp gene and MOX terminator district, while BglII restriction enzyme site is introduced in downstream;
Primer 2 9:5'-ATGGCTTTGTGGAGACCATCAGACA-3 ' (SEQ ID NO:35)
Primer 30:5'-GAagatctCAATCTCCGGAATGGTGATCTG-3 ' (SEQ ID NO:36)
Using the FMD promoter region of above-mentioned PCR amplification acquisition, 18hp and MOX terminator district as template, with primer 27 and primer
30 amplifications obtain the 18hp expression cassette (FMD promoter) that size is 2.9Kb, while carrying NotI restriction enzyme site in upstream, under
Trip carries BglII restriction enzyme site.
It is cloned into pRMHP2.1 carrier by the 18hp expression cassette that NotI+BglII double digestion carries FMD promoter, structure
Build recombination expressed by Hansenula yeast plasmid pRMHP2.1-FMD18hp.
Embodiment 5: the generation of recombination Hansenula yeast cell
(1) extraction and digestion of recombinant expression construct constitution grain
Picking is transformed into the E. coli clones of the recombinant expression construct constitution grain obtained in embodiment 4, after expanding culture
Plasmid is extracted using E.Z.N.A Plasmid Mini Kit kit (Omega Bio-Tek company), and is carried out with Bgl II
Single endonuclease digestion is recycled using E.Z.N.A Gel Extraction Kit kit (OmegaBio-Tek company), with 50 μ L
It is preheated to 55 DEG C of sterile water to be eluted, it is quantitative to carry out DNA by measurement OD260, and the segment of linearisation is diluted to
100ng/ μ l, is stored in -20 DEG C of refrigerators, spare.
(2) processing of Hansenula yeast cell
Picking Hansenula yeast strains A TCC26012 single colonie accesses in the small test tube of the YPD fluid nutrient medium containing 5ml, 37
DEG C culture 10-12 hours;Take bacterium solution 5ml to be forwarded in 200mlYPD culture medium, 37 DEG C culture 4-5 hours, until OD600 is about
1.2-1.5 being centrifuged 10min in 4000rpm;With 200ml 0.1mol/L phosphate buffer (DTT containing 25mmol/L, pH7.5)
Thallus is resuspended, mixes well, is centrifuged 10min in 37 DEG C of incubations 30min, 4000rpm, abandons supernatant, stay thallus.With the STM of pre-cooling
Solution 200ml washes thallus, and thallus pressure-vaccum is uniform, is centrifuged 3min in 4 DEG C of 4000rpm, abandons supernatant, stay precipitating.It is molten with ice-cold STM
Thallus is resuspended in liquid 100ml, is centrifuged 3min in 4 DEG C of 4000rpm, abandons supernatant, stay precipitating.It is ice-cold with 80-200 μ l according to biomass
Thallus is resuspended in STM solution, and bacterium solution is transferred in the centrifuge tube after high pressure, and ice bath prepares conversion.
(3) electrotransformation of Hansenula yeast cell
By plasmid: thallus=1: 2 amount, which is added, recombinates 15 μ l of expressed by Hansenula yeast plasmid, 30 μ l of bacterium solution, and abundant pressure-vaccum is equal
It is even, it is placed in be transformed in ice bath;It will be impregnated in advance with alcohol, and after ultraviolet irradiation, take out, add in the electric revolving cup that -20 DEG C refrigerate
Enter plasmid thallus mixed liquor;It shocks by electricity by the condition of voltage 2500V, 150 Ω of resistance, 50 μ F of capacitor;It is rapidly added after electric shock
1ml has been balanced to the YPD solution of room temperature, is transferred in EP pipe after mixing gently;Thallus after electricity is turned is put in 37 DEG C of water-baths
1h is set, is gently overturned 3 times at interval of 15min;It will be incubated for the bacterium solution of 1h, has been centrifuged 10min in 4000rpm, abandons supernatant;With 200 μ
Thallus is resuspended in lYPD solution, is coated in the YPD plate of the Zeocin containing 0.25mg/ml with 100 μ l/ plates, cultivates in 37 DEG C of inversions
3-5 days.
(4) passage, the stabilization of expressed by Hansenula yeast bacterial strain are recombinated
The recombinant bacterial strain single colonie grown in picking Zeocin resistant panel, is inoculated in 5ml Zeocin containing 0.25mg/ml
YPD fluid nutrient medium in, in 37 DEG C, 200rpm shaking table culture 24-36 hours, until OD value is up to after 50, with 1: 1000 ratio
It transfers in the YPD fluid nutrient medium of 5ml Zeocin containing 0.25mg/ml, culture to OD value is up to after 50, then with 1: 1000 ratio
Example is transferred in the YPD fluid nutrient medium of 5ml Zeocin containing 0.25mg/ml, and so on, it is continuous to pass 10 times and carry out strain
Preservation.Preservation system is bacterium solution: 60% glycerol=1: 1, amount saves strain as needed, usually+400 μ of 400 μ l bacterium solution
L60% glycerol;
The recombination expressed by Hansenula yeast bacterial strain access 5ml for reaching 10 times is free of to the YPD fluid nutrient medium of Zeocin resistance
In, in 37 DEG C, 200rpm shaking table culture to OD value up to after 50, transferred in 5ml YPD fluid nutrient medium with 1: 1000 ratio,
And so on, it is continuously passed 5 times in the YPD fluid nutrient medium without Zeocin resistance.
By the YPD plate of bacterium solution coating G418 containing 10mg/ml after stabilization, cultivates 2-3 days in 32 DEG C of inversions, put down from each
The eugonic single colonie of picking carries out copy number detection in plate.
Embodiment 6: the exogenous polynucleotide copy number detection of recombination Hansenula yeast cell
(1) extraction of pastoris genomic dna and quantitative
The eugonic yeast strain single bacterium that inoculation embodiment 5 obtains, which is fallen in the YPD fluid nutrient medium of 5ml, cultivates
Base, 37 DEG C of cultures 16~for 24 hours;2ml Yeast Cultivation liquid is taken, room temperature 4500g is centrifuged 3min and collects thallus;It is molten using 500 μ l SCED
Bacterium is resuspended in liquid (1mol/L sorbierite, 10mmol/L sodium citrate, 10mmol/L EDTA, 10mmol/L DTT dithiothreitol (DTT))
Body, and 50mg bead is added, 5min fullys shake, 50 μ l 10mg/ml lywallzymes, 37 DEG C of warm bath 1h are added;It is added 60 μ l's
10%SDS, the Proteinase K of 30 μ l, the RNaseA enzyme of 10 μ l are placed at room temperature for and cultivate 2h in 55 DEG C of water-bath after ten minutes;Add
Enter 350 μ l saturated phenols and 350 μ l chloroforms, in 13000rpm after being sufficiently mixed, is centrifuged 10 minutes, the upper liquid after collecting layering;
Isometric (about 700 μ l) chloroform is added, in 13000rpm, is centrifuged 10 minutes, the upper liquid after collecting layering;Add into upper liquid
The 3mol/L sodium acetate solution for entering 140 μ l adds 700 μ l isopropanols, is placed at room temperature for 5min after mixing after mixing gently, in
13000rpm is centrifuged 10 minutes.Supernatant is abandoned, 70% ethyl alcohol of 1ml is added and is cleaned, in 13000rpm, is centrifuged 10 minutes,
Remove supernatant, DNA precipitating is placed in be placed at room temperature for 30min after, 100 μ l TE dissolution is added.Genomic DNA is carried out by measurement OD260
Quantify, and the segment of linearisation is diluted to 100ng/ μ l, is stored in -20 DEG C of refrigerators, it is spare.
(2) Southern immunoblot method carries out quantifying for exogenous polynucleotide copy number
A: probe preparation
I) PCR amplification of MOX promoter region segment
Using pRMHP2.1-18hp as template, size is obtained as the MOX promoter of 493bp with primer 31 and the amplification of primer 32
Area;
Primer 31:5'-CGTAGTACTTGTTCGCGTCGCTGTA-3 ' (SEQ ID NO:37)
Primer 32:5'-GCAGTGGACGACCTCATGGTAAACT-3 ' (SEQ ID NO:38)
Ii) the PCR amplification of HPV18L1 genetic fragment
Using pRMHP2.1-18hp as template, size is obtained as the HPV18L1 base of 481bp with primer 33 and the amplification of primer 34
Because of segment;
Primer 33:5 '-GCTGGTGGAGGTAACAAACAGGACA-3 ' (SEQ ID NO:39)
Primer 34:5 '-GCAACGTAGAGAAATCCATCGCACC-3 ' (SEQ ID NO:40)
Iii) prepared by probe
Using Roche company DIG DNA Labeling and Detection kit kit (Cat No:
11093657910) probe preparation is carried out.Specific steps are as follows: the 10 above-mentioned PCR products of μ l (200ng/ μ l) are added into EP tubule,
And sealed up with sealed membrane, boiling water boils 10 minutes.It is immediately placed in the dehydrated alcohol capsule of pre-cooling (- 20 DEG C) and (cools down suddenly).
Pipe outer wall ethyl alcohol is dried, is centrifuged (about 10s), sequentially adds 5 μ l tiny electrolytic cell water, 2 μ l 10x Hexanucleotide
Mix, 2 μ l 10x dTP Labeling Mixture, 1 μ l 7Klenow Enzyme (1abeling grade) are mixed, sealing
Film sealing.37 DEG C of water-baths are stayed overnight, -20 DEG C of preservations.
B:Southern trace
Using digoxin hybridization check kit I (the Cat No:DIGD- of Beijing Mei Laibo medical science and technology Co., Ltd
110) and the efficient hybridization solution of HyB (Cat No:Hyb-500) is according to product description progress Southern trace detection.
3) copy number of different recombination Hansenula yeast bacterial strains compares
Using the Southern trace testing result that MOX promoter region segment is probe as shown in Fig. 2A, as the result is shown:
HP/pRMHP2.1-18wt bacterial strain is (through passage and stabilizing step after recombinant plasmid pRMHP2.1-18wt electrotransformation, in 10mg/ml
G418 plate in screen obtain) copy number be greater than 63;HP/pRMHP2.1-18sc bacterial strain (recombinant plasmid pRMHP2.1-18sc
After electrotransformation through passage and stabilizing step, in the g418 plate of 10mg/ml screen obtain) copy number be greater than 63;HP/
PRMHP2.1-18pp bacterial strain is (through passage and stabilizing step after recombinant plasmid pRMHP2.1-18pp electrotransformation, in 10mg/ml's
In g418 plate screen obtain) copy number be greater than 31;HP/pRMHP2.1-18hp bacterial strain (recombinant plasmid pRMHP2.1-18hp electricity
After conversion through passage and stabilizing step, in the g418 resistance of 10mg/ml screen obtain) copy number be greater than 31;HP/
PRMHP2.1-18hp-2 bacterial strain is (through passage and stabilizing step after recombinant plasmid pRMHP2.1-18hp electrotransformation, in 1mg/ml's
Screening and obtain in g418 plate) copy number is greater than 7 but less than 15.
Using the Southern trace testing result that HPV18L1 genetic fragment is probe as shown in Fig. 2 B, as the result is shown:
HP/pRMHP2.1-FMD18hp bacterial strain (after recombinant plasmid pRMHP2.1-FMD18hp Electroporation Transformation through passage and stabilizing step,
Screen and obtain in the g418 plate of 10mg/ml) exogenous polynucleotide integrates copy number and HP/pRMHP2.1-18hp bacterial strain phase
Closely.
The preparation of the prokaryotic expression and rabbit polyclonal antibody of embodiment 7:HPV18 L1 albumen
(1) PCR amplification of HPV18 L1 gene and expression plasmid clone's building
Using pRMHP2.1-18pp as template, size is obtained as the HPV18L1 base of 1540bp with primer 35 and the amplification of primer 36
NdeI restriction enzyme site is introduced because of segment (without terminator codon), while in upstream, introduces XhoI in downstream;
Primer 35:5 '-ggaattccatATGGCTTTGTGGAGACCTTCTGACA-3 ' (SEQ ID NO:41)
Primer 36:5 '-CCGCTCGAGCTTTCTAGCTCTAACTCTAACT-3 ' (SEQ ID NO:42)
18pp gene fragment clone is entered in pET43.1a carrier (Novagen company) by NdeI+XhoI double digestion, it will
The correct recombinant plasmid of sequence verification is named as pET43.1a-18pp.
(2) inducing expression of the HPV18 L1 albumen in Escherichia coli
Recombinant plasmid pET43.1a-18pp converts E. coli expression strains BL21-CodonPlus (DE3)-RIPL, obtains
Engineering bacteria BL21-CodonPlus (DE3)-RIPL/pET43.1a-18pp must be expressed.Picking single colonie accesses the liquid of LB containing 5ml
In the test tube of culture medium (the 50 μ g/ml containing Amp), IPTG is added to final concentration in 37 DEG C of cultures to OD600 when being about 0.8
0.5mmol/L, induction time 4h, while the control tube that setting does not induce.Bacterium solution is collected, SDS-PAGE detects recombinant protein
Expression (Fig. 3 A).
(3) purifying of HPV18 L1 albumen
Preparation of samples: picking expression engineering bacteria BL21-CodonPlus (DE3)-RIPL/pET43.1a-18pp single colonie connects
In the test tube for entering LB liquid medium containing 5ml (the 50 μ g/ml containing Amp), 37 DEG C of overnight incubations, next day is connect by 1% inoculum concentration
In the 1L triangular flask for entering LB liquid medium containing 400ml (the 50 μ g/ml containing Amp), until IPTG is added extremely when OD600 is about 0.8
Final concentration 0.5mmol/L collects bacterium solution after inducing 4h and is centrifuged, bacterial sediment is resuspended in PBS in the ratio of 1: 10 (g/ml)
Precipitating is collected by centrifugation in solution, carrying out ultrasonic bacteria breaking (5s, 5s, 400W, the 60cycles) under ice bath, 8000r/min centrifugation 15min.
Purification process (Fig. 3 B): solution (50mM phosphate, 500mM is added in the ratio of 1: 10 (g/ml) in ultrasound precipitation
NaCl, 20mM imidazoles, 8M urea, pH8.0) in be sufficiently stirred dissolution, 8000r/min is centrifuged 15min, collects 0.45 μm of film mistake of supernatant
Filter.It is splined on Chelating Sepharose FF chromatography media, with solution (50mM phosphate, 150mM NaCl, 500mM miaow
Azoles, 8M urea, pH8.0) elution, collect destination protein eluting peak.Dialysis removal imidazoles.
(4) prepared by rabbit polyclonal antibody
Rabbit is immunized and serum collection: with 2 new zealand rabbits of HPV18 L1 protein immunization of the prokaryotic expression of purifying, exempting from
Epidemic disease method uses back multi-point injection method, and immune programme is the 0th, 3,6,8 week each immune primary, and immunizing dose is 250 μ g/
Secondary, antigen need to be injected again after Freund's complete adjuvant (FCA) or incomplete Freund's adjuvant (FIA) are fully emulsified, exempt from for the first time
Epidemic disease application FCA, follow-up immunization application FIA were taken a blood sample by arteria carotis in the 9th week and separate serum, and every rabbit can separate serum
40-60ml。
Antibody purification (Fig. 3 C): antiserum is after 0.45 μm of filtering, and upper prop is in chromatography media rProtein A
Sepharose FF carries out affinitive layer purification.Under pH neutrallty condition, antibody is incorporated on chromatography media, with citric acid-lemon
Lemon acid sodium buffer (pH4.0) elution, collects antibody elution peak, and 1M Tris.Cl, pH9.0 is used to neutralize to pH neutrality immediately.
Embodiment 8: the expression study of difference recombination Hansenula yeast bacterial strain
(1) inducing expression of Hansenula yeast bacterial strain is recombinated
Picking recombinates Hansenula yeast single colonie from plate, accesses in the small test tube of the YPG fluid nutrient medium containing 5ml, 37
DEG C culture 18-24 hours;By bacterium solution switching in the 500ml triangular flask of the induced medium of YPM containing 100ml, initial density is
OD600nm=1 induces 72 hours in 37 DEG C of shaking tables, final concentration of 0.5% methanol solution was added in bacterium solution every 12 hours
(i.e. 0.5ml/ bottles).
Bacterium solution after taking 25ml to induce is transferred in the centrifuge tube of 50ml, is centrifuged 10min in 8000rpm, is abandoned supernatant;With
Bacterial sediment is resuspended in the cell cracking of 50ml, after mixing well, presses in Ultrasound Instrument and " power 60%, time 20min, opens 5s, closes
The ultrasonication program of 5s " carries out bacterial cell disruption, needs to keep ice bath in shattering process;By the bacterium solution of ultrasonication, in 8000rpm
It is centrifuged 10min, collection supernatant freezes spare in -20 DEG C.
(2) detection of expression of Hansenula yeast bacterial strain HPV18 L1 albumen is recombinated
The detection of HPV18 L1 protein expression level is carried out using western blot semi-quantitative method
Glue and electrophoresis: preparing 12% polyacrylamide gel, measuring samples and standard items is added, upper layer glue is with 8V/
The voltage of cm, separation gel carry out electrophoresis with the voltage of 15V/cm, until stopping electrophoresis when bromophenol blue reaches separation gel bottom, cutting
Separation gel;
Semidry method transferring film: pvdf membrane first uses methyl alcohol process 15 seconds, is soaked into positive liquid again extremely after being rinsed 3 times with deionized water
Few 5min;Running gel is soaked in negative electrode solution, installs electrotransfer device in order, and the electric current of 150mA carries out electricity and turns 35-45min;
After the completion of transferring film, check whether pre-dyed protein marker band is completely transferred.
Closing: film is added in the valve bag for having 5% milk of 20ml with tweezers, bubble is squeezed out, uses plastic film sealing
Machine sealing.Shaking table shakes closing 1 hour slowly or (should be put into refrigerator cold-storage preservation overnight) overnight.
Primary antibody is incubated for: the rabbit-anti HPV18 L1 albumen prepared mostly anti-be added with 1/200 ratio is filled 5% milk
Valve bag in, film is put into after mixing, squeeze out bubble, sealed with plastic film sealing machine.Shaking table shakes incubation 1.5 hours slowly.
It washes film: taking the film out and washed 5 times with TBST, about 100ml, time are 5 minutes every time.Last time is 10 minutes.
Secondary antibody is incubated for: the goat-anti rabbit secondary antibody of HRP label is added to the valve bag for filling 5% milk with 1/1000 ratio
In, film is put into after mixing, bubble is squeezed out, is sealed with plastic film sealing machine.Shaking table shakes incubation 2 hours slowly.
It washes film: taking the film out and washed 5 times with TBST, about 100ml, time are 5 minutes every time.Last time is 10 minutes.
Colour developing: film is put into developing solution, and shaking table, which is shaken slowly to band, to be occurred, and is rinsed color development stopping with flowing water, is dried laggard
Row is taken pictures.
(3) result
It compares and integrates the influence that copy number expresses HPV18 L1 albumen in Hansenula yeast bacterial strain, it can be in Fig. 4
Observe that the expression of the higher HP/pRMHP2.1-18hp bacterial strain of copy number (copy number is greater than 31) is apparently higher than HP/
PRMHP2.1-18hp-1 bacterial strain (copy number is greater than 7 but less than 15), display copy number has HPV18L1 protein expression level
Direct to influence, the expression of height copy integron is higher than low-copy integron.
For the expression of different HPV18 L1 genes, HPV natural gene 18wt, the 18sc expressed for saccharomyces cerevisiae
And the expression of the 18pp for Pichia anomala expression is well below the gene 18hp for being directed to Hansenula yeast optimization design
(Fig. 4), display is for Hansenula yeast host genetic codon bias complex optimum for HPV18 L1 albumen in Hansenula yeast bacterium
Realize that high level expression is vital in strain.
For FMD promoter, western blot as the result is shown its also can efficiently induce HPV18L1 protein expression, express water
It is flat close with MOX promoter.
Embodiment 9:HPV18 L1 recombinates zymotechnique and the purifying process research of Hansenula yeast bacterial strain
Fermentation seed liquid: 1 is taken to freeze glycerol stock (HP/pRMHP2.1-18hp).100 μ l access 5ml is drawn after thawing
In YPD culture medium, 200rpm (rev/min), 30 DEG C of culture 20hr, A600nm about 2-3 respectively draw 1ml access 2 after assay approval
In bottle 500ml YPD culture medium, 200rpm, 30 DEG C of culture 20hr.A600nm about 10-15 is used as fermentation seed after assay approval
Liquid is stand-by.
Ferment control: fermentation initial culture medium contains yeast powder 300g, peptone 150g, glycerol 100g, basic salt (K2SO4
273g, MgSO4100g, 85%H3PO4400ml, KOH 62g), 10L purified water sufficiently dissolves, and 30L fermentor (Shanghai is added
Hundred logical sequences) in, purified water is settled to 14L, and 121 DEG C, 60ml PTM1 liquid microelement is added in 30min sterilizing after being cooled to 30 DEG C
(CuSO4·5H2O 6.0, KI 0.088g, MnSO4·H2O 3.0g, Na2MoO4·2H2O 0.2g, H3BO30.02g, CoCl2·
6H2O 0.5g, ZnCl220.0g FeSO4·7H2O 65.0g, Biotin 0.2g, dense H2SO45.0ml, purified water are settled to
1L, 0.22 μm of membrane filtration degerming), ammonium hydroxide adjusts pH5.5, is inoculated with 2 bottles of 500ml fermentation seed liquids, fermentation volume is at this time
15L.Starting speed of agitator is 200rpm, air mass flow 0.5Nm3/hr, tank press 0.5bar, and control oxygen dissolving value is 20- in fermentation
80%.After the initial growth phase maintains about 19hr, bacterium solution A600nmReach 20 or so, dissolved oxygen starts rapid increase, starts with 100ml/
Hr flow velocity flow feeding culture medium (50% glycerol (W/V), 12ml PTM1) enters stream plus growth period at this time.After cultivating about 6hr,
Bacterium solution A600nmReach 80 or so, stop stream and add, ammonium hydroxide adjusts pH value to 6.0.Start stream after dissolved oxygen bottom out plus methanol (contains
12ml/L PTM1) enter the inducing expression phase, the initial flow rate of methanol is 50ml/hr, is sampled per hour, methanol electrode (East China
Science and engineering) measurement methanol concentration, by adjusting methanol feeding rate control methanol concentration < 5g/L, and collect wet thallus ultrasonication
Afterwards for western blot detection (5 times of sample dilutions), western blot testing result is as shown in Figure 5.
Lower tank centrifugation: after induction 10hr, lower tank, 6000rpm, 4 DEG C, 30min (centrifuge model Beckman J-26XP,
Rotor model JLA 8.1000) wet thallus is collected by centrifugation.- 20 DEG C of wet thallus of harvest freeze.
Bacterial cell disruption: taking the HPV 18 of -20 DEG C of preservations to express wet thallus, is added according to the ratio of 10ml/g wet thallus
The cleaning of 0.9% physiological saline.After cell washing, disruption buffer is added by 20ml buffer/g wet thallus and (contains 0.5mol/L
NaCl, 0.02% Tween-80,0.05mol/L MOPS) sufficiently dissolution, use high-pressure homogenization (high pressure homogenizer model Niro
NS1001L2K it) is crushed, cracking pressure 1500bar, circulation is 5 times broken, microscopy percentage of damage > 90%.Bacterial cell disruption liquid warp
8000rpm, 4 DEG C, supernatant is collected by centrifugation in 30min (centrifuge model Beckman J-26XP, rotor model JA-10), is added
45% ammonium sulfate precipitation 30min, 8000rpm, 4 DEG C, 30min (centrifuge model Beckman J-26XP, rotor model JA-10)
Supernatant is collected by centrifugation.
Chromatographic purifying: the bacterial cell disruption supernatant filtered through 1 μm is splined on chromatography media POROS 50HS (Applied
Biosystems), destination protein is adsorbed on chromatography media, and 0.5M~1.5M NaCl gradient elution, destination protein is obtained with impurity
Initial gross separation is obtained, the HPV18 L1 albumen (Fig. 6 A) of elution is collected.The just pure HPV18 L1 VLPs albumen of this step is splined on layer
Medium Macro-Prep ceramic hydroxyapatite (Type II, 40 μm) is analysed, destination protein is incorporated on chromatography media, 20~
200mM phosphate concn gradient elution, destination protein are separated with impurity, collect the HPV18 L1 albumen (Fig. 6 B) of elution.
Embodiment 10: the HPV18 L1 recombinant protein of transmission electron microscope observing purifying
With the HPV18 L1 protein sample of 2 times of sterile water dilutions after purification, a droplet is dripped on cured disk.Copper mesh is taken to make have branch
The surface for holding film is contacted with sample liquid surface, is stood 1min and is taken out, takes out copper mesh, extra drop is absorbed with filter paper item, is slightly dried in the air
It is dry.2% acetic acid uranium solution is taken, drips a droplet on cured disk.The copper mesh for being adsorbed with sample is placed in dye liquor surface (sample and dye liquor
Contact), stand 2min.Copper mesh is taken out, extra drop is absorbed with filter paper item, is dried under incandescent lamp.Using JEOL-1400 model
Transmission electron microscope (Japan Electronics) observation VLP particle shape is simultaneously taken pictures (shown in result figure 7).
Embodiment 11: with the immunogenicity research for the HPV18 L1 VLP that Hansenula yeast is prepared by recombinant
Using measurement humoral immunity effect ED50The immunogenicity of the method evaluation HPV18 L1 VLP of (median effective dose)
(1) mouse is immune: 85 6-8 week old Balb/c female mices (are ground purchased from Chinese Academy of Medical Sciences experimental animal
Study carefully institute), cleaning grade raising.6 groups are divided into, it, will by required immunizing dose including 5 experimental groups and 1 control group
HPV18 L1 protein sample is diluted (table 1).Immune programme are as follows: the 0th, 3,6 week each immune primary, 14 after last time is immune
It kills mouse and separates serum.
Table 1
(2) serological conversion rate after mouse, specific steps are immunized in ELISA method measurement HPV18 L1 VLP are as follows: slow with coating
Escherichia coli recombination HPV18 L1 albumen is diluted to 0.5 μ g/ml by fliud flushing, and every hole adds 0.1ml, and 4 DEG C overnight.Next day washing buffer
Liquid washs 3 times, gets rid of most residual liquid.With antibody diluent closing 30 minutes, washing buffer was washed 3 times, was detected after drying,
Or 4 DEG C of damp proof preservations after drying.Each mice serum sample is diluted with 1: 10000 with sample diluting liquid, takes 0.1ml in upper
It states in the reacting hole being coated with, sets 37 DEG C and be incubated for 1 hour, wash 5 times.(while doing blank, negative hole control).In reacting hole
The sheep anti-mouse igg secondary antibody 0.1ml of the HRP label of 1: 5000 diluted fresh of antibody diluent is added, 37 DEG C are incubated for 30 minutes,
Washing 5 times, last time are washed with distilled water.It is added the tmb substrate solution 0.1ml of Extemporaneous in each reacting hole, 37 DEG C
Colour developing 10 minutes.50 μ l 2M sulfuric acid 0.05ml are added in each reacting hole to terminate reaction.In microplate reader, at 450nm
(630 be reference wavelength), surveys each hole OD value after returning to zero with blank control wells.Cutoff value calculates and positive findings determine:
Cutoff value=negative control value × 2.1;Sample OD value > Cutoff value is then judged to the positive.
(3) humoral immunity effect ED50Calculating
According to following table 2 calculated result, the humoral immunity effect ED of HPV18 L1 VLP50Value is 0.222 μ g, it is shown that
HPV18 L1 VLP has good immunogenicity.
Wherein: turning dilution higher than 50% sun is 4, and turning dilution lower than 50% sun is 8.Pass through calculate obtain: distance than
Being higher than the dilution that 50% sun turns for 0.1736, log10 is 0.602, ED50Logarithm be 0.6543,50% sun turns dilution and is
4.51.So ED50Value is 0.222 μ g.
Sequence table
<110>Beijing Abzymo Biosciences Technology Co., Ltd.
<120>method for generating HPV18 L1 albumen with expressed by Hansenula yeast system
<130> 2736
<160> 42
<170> PatentIn version 3.3
<210> 1
<211> 507
<212> PRT
<213> Human Papillomavirus
<400> 1
Met Ala Leu Trp Arg Pro Ser Asp Asn Thr Val Tyr Leu Pro Pro Pro
1 5 10 15
Ser Val Ala Arg Val Val Asn Thr Asp Asp Tyr Val Thr Arg Thr Ser
20 25 30
Ile Phe Tyr His Ala Gly Ser Ser Arg Leu Leu Thr Val Gly Asn Pro
35 40 45
Tyr Phe Arg Val Pro Ala Gly Gly Gly Asn Lys Gln Asp Ile Pro Lys
50 55 60
Val Ser Ala Tyr Gln Tyr Arg Val Phe Arg Val Gln Leu Pro Asp Pro
65 70 75 80
Asn Lys Phe Gly Leu Pro Asp Asn Ser Ile Tyr Asn Pro Glu Thr Gln
85 90 95
Arg Leu Val Trp Ala Cys Ala Gly Val Glu Ile Gly Arg Gly Gln Pro
100 105 110
Leu Gly Val Gly Leu Ser Gly His Pro Phe Tyr Asn Lys Leu Asp Asp
115 120 125
Thr Glu Ser Ser His Ala Ala Thr Ser Asn Val Ser Glu Asp Val Arg
130 135 140
Asp Asn Val Ser Val Asp Tyr Lys Gln Thr Gln Leu Cys Ile Leu Gly
145 150 155 160
Cys Ala Pro Ala Ile Gly Glu His Trp Ala Lys Gly Thr Ala Cys Lys
165 170 175
Ser Arg Pro Leu Ser Gln Gly Asp Cys Pro Pro Leu Glu Leu Lys Asn
180 185 190
Thr Val Leu Glu Asp Gly Asp Met Val Asp Thr Gly Tyr Gly Ala Met
195 200 205
Asp Phe Ser Thr Leu Gln Asp Thr Lys Cys Glu Val Pro Leu Asp Ile
210 215 220
Cys Gln Ser Ile Cys Lys Tyr Pro Asp Tyr Leu Gln Met Ser Ala Asp
225 230 235 240
Pro Tyr Gly Asp Ser Met Phe Phe Cys Leu Arg Arg Glu Gln Leu Phe
245 250 255
Ala Arg His Phe Trp Asn Arg Ala Gly Thr Met Gly Asp Thr Val Pro
260 265 270
Gln Ser Leu Tyr Ile Lys Gly Thr Gly Met Arg Ala Ser Pro Gly Ser
275 280 285
Cys Val Tyr Ser Pro Ser Pro Ser Gly Ser Ile Val Thr Ser Asp Ser
290 295 300
Gln Leu Phe Asn Lys Pro Tyr Trp Leu His Lys Ala Gln Gly His Asn
305 310 315 320
Asn Gly Val Cys Trp His Asn Gln Leu Phe Val Thr Val Val Asp Thr
325 330 335
Thr Arg Ser Thr Asn Leu Thr Ile Cys Ala Ser Thr Gln Ser Pro Val
340 345 350
Pro Gly Gln Tyr Asp Ala Thr Lys Phe Lys Gln Tyr Ser Arg His Val
355 360 365
Glu Glu Tyr Asp Leu Gln Phe Ile Phe Gln Leu Cys Thr Ile Thr Leu
370 375 380
Thr Ala Asp Val Met Ser Tyr Ile His Ser Met Asn Ser Ser Ile Leu
385 390 395 400
Glu Asp Trp Asn Phe Gly Val Pro Pro Pro Pro Thr Thr Ser Leu Val
405 410 415
Asp Thr Tyr Arg Phe Val Gln Ser Val Ala Ile Thr Cys Gln Lys Asp
420 425 430
Ala Ala Pro Ala Glu Asn Lys Asp Pro Tyr Asp Lys Leu Lys Phe Trp
435 440 445
Asn Val Asp Leu Lys Glu Lys Phe Ser Leu Asp Leu Asp Gln Tyr Pro
450 455 460
Leu Gly Arg Lys Phe Leu Val Gln Ala Gly Leu Arg Arg Lys Pro Thr
465 470 475 480
Ile Gly Pro Arg Lys Arg Ser Ala Pro Ser Ala Thr Thr Ser Ser Lys
485 490 495
Pro Ala Lys Arg Val Arg Val Arg Ala Arg Lys
500 505
<210> 2
<211> 1524
<212> DNA
<213> Artificial
<220>
<223> 18wt
<400> 2
atggctttgt ggcggcctag tgacaatacc gtatatcttc cacctccttc tgtggcacga 60
gttgtaaata ccgatgatta tgtgactcgc acaagcatat tttatcatgc tggcagctct 120
agattattaa ctgttggtaa tccatatttt agggttcctg caggtggtgg taataagcag 180
gatattccta aggtttcggc ataccaatat agagtattta gggtgcagtt acctgaccca 240
aataaatttg gtttacctga taatagtatt tataatcctg aaacacaacg tttagtgtgg 300
gcctgtgctg gagtggaaat tggccgtggt cagcctttag gtgttggcct tagtgggcat 360
cccttttata ataaattaga tgacactgaa agttcccatg ccgccacgtc taatgtttct 420
gaggacgtta gggacaatgt gtctgtagat tataagcaga cacagttatg tattttgggc 480
tgtgcccctg ctattgggga acactgggct aaaggcactg cttgtaaatc gcgtccttta 540
tcacagggcg attgcccccc tttagaactt aaaaacacag ttttggaaga tggtgatatg 600
gtagatactg gatatggtgc catggacttt agtacattgc aagatactaa atgtgaggta 660
ccattggata tttgtcagtc tatttgtaaa tatcctgatt atttacaaat gtctgcagat 720
ccttatgggg attccatgtt tttttgctta cggcgtgagc agctttttgc taggcatttt 780
tggaataggg caggtactat gggtgacact gtgcctcaat ccttatatat taaaggcaca 840
ggtatgcgtg cttcacctgg cagctgtgtg tattctccct ctccaagtgg ctctattgtt 900
acctctgact cccagttgtt taataaacca tattggttac ataaggcaca gggtcataac 960
aatggtgttt gctggcataa tcaattattt gttactgtgg tagataccac tcgcagtacc 1020
aatttaacaa tatgtgcttc tacacagtct cctgtacctg ggcaatatga tgctaccaaa 1080
tttaagcagt atagcagaca tgttgaggaa tatgatttgc agtttatttt tcagttgtgt 1140
actattactt taactgcaga tgttatgtcc tatattcata gtatgaatag cagtatttta 1200
gaggattgga actttggtgt tccccccccg ccaactacta gtttggtgga tacatatcgt 1260
tttgtacaat ctgttgctat tacctgtcaa aaggatgctg caccggctga aaataaggat 1320
ccctatgata agttaaagtt ttggaatgtg gatttaaagg aaaagttttc tttagactta 1380
gatcaatatc cccttggacg taaatttttg gttcaggctg gattgcgtcg caagcccacc 1440
ataggccctc gcaaacgttc tgctccatct gccactacgt cttctaaacc tgccaagcgt 1500
gtgcgtgtac gtgccaggaa gtaa 1524
<210> 3
<211> 1524
<212> DNA
<213> Artificial
<220>
<223> 18sc
<400> 3
atggctttgt ggcggcctag tgacaatacc gtataccttc cacctccttc tgtggcaaga 60
gttgtaaata ctgatgatta tgtgactcgc acaagcatat tttatcatgc tggcagctct 120
agattattaa ctgttggtaa tccatatttt agggttcctg caggtggtgg caataagcag 180
gatattccta aggtttctgc ataccaatat agagtatttc gggtgcagtt acctgaccca 240
aataaatttg gtttacctga taatagtatt tataatcctg aaacacaacg tttagtgtgg 300
gcctgtgctg gagtggaaat tggccgtggt cagcctttag gtgttggcct tagtgggcat 360
ccattttata ataaattaga tgacactgaa agttcccatg ccgctacgtc taatgtttct 420
gaggacgtta gggacaatgt gtctgtagat tataagcaga cacagttatg tattttgggc 480
tgtgcccctg ctattgggga acactgggct aaaggcactg cttgtaaatc gcgtccttta 540
tcacagggcg attgcccccc tttagaactt aagaacacag ttttggaaga tggtgatatg 600
gtagatactg gatatggtgc catggacttt agtacattgc aagatactaa atgtgaggta 660
ccattggata tttgtcagtc tatttgtaaa tatcctgatt atttacaaat gtctgcagat 720
ccttatgggg attccatgtt tttttgctta cgacgtgagc agctttttgc taggcatttt 780
tggaataggg caggtactat gggtgacact gtgcctcaat ccttatatat taaaggcaca 840
ggtatgcgtg cttcacctgg cagctgtgtg tattctccct ctccaagtgg ctctattgtt 900
acctctgact cccagttgtt taataaacca tattggttac ataaggcaca gggtcataac 960
aatggtatct gctggcataa tcaattattt gttactgtgg tagataccac tcgtagtacc 1020
aatttaacaa tatgtgcttc tacacagtct cctgtacctg ggcaatatga tgctaccaaa 1080
tttaagcagt atagcagaca tgttgaagaa tatgatttgc agtttatttt tcagttatgt 1140
actattactt taactgcaga tgttatgtcc tatattcata gtatgaatag cagtatttta 1200
gaggattgga actttggtgt tccccccccg ccaactacta gtttggtgga tacatatcgt 1260
tttgtacaat ctgttgctat tacctgtcaa aaggatgctg caccagctga aaataaggat 1320
ccctatgata agttaaagtt ttggaatgtg gatttaaagg aaaagttttc tttggactta 1380
gatcaatatc cccttggacg taaatttttg gttcaggctg gattgcgtcg caagcccacc 1440
ataggccctc gtaaacgttc tgctccatct gccactacgt cttctaaacc tgccaagcgt 1500
gtgcgtgtac gtgccaggaa gtaa 1524
<210> 4
<211> 1524
<212> DNA
<213> Artificial
<220>
<223> 18pp
<400> 4
atggctttgt ggagaccttc tgacaacact gtttacttgc cacctccatc cgttgctaga 60
gttgttaaca ctgatgacta cgttactaga acttctattt tctaccacgc tggttcctct 120
agattgttga ctgttggtaa cccttacttt agagttccag ctggtggtgg taacaagcaa 180
gatattccta aggtttccgc ttaccaatac agagttttca gagttcaatt gccagaccct 240
aacaagtttg gtttgccaga tacttctatt tacaaccctg agactcaaag attggtttgg 300
gcttgtgctg gtgttgaaat tggtagaggt caaccattgg gtgttggttt gtccggtcat 360
cctttctaca acaagttgga cgatactgag tcttcccacg ctgctacttc taacgtttcc 420
gaagacgtta gagataacgt ttctgttgac tacaagcaaa ctcaattgtg tattttgggt 480
tgtgctccag ctattggtga gcattgggct aagggtactg cttgtaagtc cagacctttg 540
tctcaaggtg attgtccacc tttggaattg aagaacactg ttttggagga cggtgatatg 600
gttgacactg gttacggtgc tatggatttc tccactttgc aagacactaa gtgtgaagtt 660
ccattggata tttgtcaatc tatttgtaag taccctgact acttgcaaat gtccgctgat 720
ccatacggtg actctatgtt cttttgtttg agaagagagc aattgttcgc tagacacttt 780
tggaacagag ctggtactat gggtgatact gttcctcaat ccttgtacat taagggtact 840
ggtatgagag cttctccagg ttcctgtgtt tactctcctt ccccatctgg ttccattgtt 900
acttctgact cccaattgtt caacaagcct tactggttgc ataaggctca aggtcacaac 960
aacggtgttt gttggcataa ccaattgttt gttactgttg ttgatactac tagatccact 1020
aacttgacta tttgtgcttc cactcaatct ccagttcctg gtcaatacga cgctactaag 1080
ttcaagcaat actccagaca cgttgaagag tacgatttgc aattcatctt ccaattgtgt 1140
actattactt tgactgctga cgttatgtct tacattcatt ccatgaactc ttccattttg 1200
gaagattgga actttggtgt tccacctcca cctactactt ctttggttga cacttacaga 1260
ttcgttcaat ccgttgctat tacttgtcaa aaggatgctg ctccagctga gaacaaggac 1320
ccttacgata agttgaagtt ttggaacgtt gacttgaagg aaaagttctc tttggatttg 1380
gaccaatacc cattgggtag aaagtttttg gttcaagctg gtttgagaag aaagcctact 1440
attggtccaa gaaagagatc cgctccttct gctactactt cctctaagcc agctaagaga 1500
gttagagtta gagctagaaa gtaa 1524
<210> 5
<211> 1524
<212> DNA
<213> Artificial
<220>
<223> 18hp
<400> 5
atggctttgt ggagaccatc agacaacacc gtctaccttc cacctccgtc ggtggctcgc 60
gtcgttaata cagatgacta tgtgacgaga acttctatct tctaccacgc agggtcctcg 120
cgtctcctga cagttggcaa cccatacttc agagttcctg ctggtggagg taacaaacag 180
gacattccaa aggtgtctgc ctaccaatac agagtcttcc gtgtgcagtt gccagaccct 240
aacaagtttg gactgccaga taactcaatc tacaaccctg agacccagag actggtctgg 300
gcttgtgcag gtgtggagat tggcagaggt caaccactgg gagtgggtct ttcgggacac 360
cctttctaca acaagctgga tgacactgaa tcttcacatg ctgctacgtc caatgtctcg 420
gaggacgtta gagataacgt gtccgttgat tacaaacaga ctcaactgtg cattctggga 480
tgtgctcctg caataggtga acattgggct aagggtactg cctgcaaatc aagaccactc 540
tcgcagggag attgtccacc tcttgagctg aagaacacag tgctggagga cggtgacatg 600
gtggatactg gatacggtgc gatggatttc tctacgttgc aagacaccaa atgcgaagtc 660
ccactggata tctgtcagtc aatctgcaag tatcctgact acctgcaaat gtctgctgat 720
ccatatggtg actctatgtt cttctgtctt aggagagagc agctctttgc aagacacttc 780
tggaatcgtg ctggtacaat gggtgacaca gtgccacagt ctctttacat caaaggaacc 840
ggtatgagag cctcgccagg atcgtgcgtc tattcgcctt ctccatctgg gtccatcgtt 900
acgagcgatt cgcaattgtt caacaagcct tactggctgc acaaagcaca gggacataac 960
aatggtgtgt gctggcacaa ccagctgttt gtgactgtcg ttgacacaac cagatcgacg 1020
aacttgacta tctgtgctag cacgcaaagc cctgtgccag gtcagtacga cgccaccaag 1080
ttcaaacagt attcaagaca tgtcgaagag tacgatctcc agttcatctt ccaactgtgc 1140
acgatcactc tcaccgctga cgttatgtcc tacattcact cgatgaactc gagcattctg 1200
gaagattgga acttcggagt tcctccacct ccaacgacct ctttggtgga cacataccgg 1260
tttgttcagt cggttgccat cacttgtcaa aaggacgctg cacctgctga gaacaaggac 1320
ccatacgaca aactgaagtt ctggaacgtt gacctcaaag agaagttctc cctggatttg 1380
gaccagtatc cgttgggcag gaagttcctg gtccaggctg gtctccgtcg gaaacctaca 1440
attggacctc gcaagagatc ggcaccatct gctaccacgt cctcgaagcc agcaaagaga 1500
gtgagggtca gagctcgcaa gtaa 1524
<210> 6
<211> 6210
<212> DNA
<213> Artificial
<220>
<223> pRMHP2.1
<400> 6
cgcggccgct tttttcctta gatcttacgg ttatccacag aatcagggga taacgcagga 60
aagaacatgt gagcaaaagg ccagcaaaag gccaggaacc gtaaaaaggc cgcgttgctg 120
gcgtttttcc ataggctccg cccccctgac gagcatcaca aaaatcgacg ctcaagtcag 180
aggtggcgaa acccgacagg actataaaga taccaggcgt ttccccctgg aagctccctc 240
gtgcgctctc ctgttccgac cctgccgctt accggatacc tgtccgcctt tctcccttcg 300
ggaagcgtgg cgctttctca atgctcacgc tgtaggtatc tcagttcggt gtaggtcgtt 360
cgctccaagc tgggctgtgt gcacgaaccc cccgttcagc ccgaccgctg cgccttatcc 420
ggtaactatc gtcttgagtc caacccggta agacacgact tatcgccact ggcagcagcc 480
actggtaaca ggattagcag agcgaggtat gtaggcggtg ctacagagtt cttgaagtgg 540
tggcctaact acggctacac tagaaggaca gtatttggta tctgcgctct gctgaagcca 600
gttaccttcg gaaaaagagt tggtagctct tgatccggca aacaaaccac cgctggtagc 660
ggtggttttt ttgtttgcaa gcagcagatt acgcgcagaa aaaaaggatc tcaagaagat 720
cctttgatct tttctacggg gtctgacgct cagtggaacg aaaactcacg ttaagggatt 780
ttggtcatga gattatcaaa aaggatcttc acctagatcc ttttaaatta aaaatgaagt 840
tttaaatcaa tctaaagtat atatgagtaa acttggtctg acagttacca atgcttaggt 900
acccctcgtg aagaaggtgt tgctgactca taccaggcct gaatcgcccc atcatccagc 960
cagaaagtga gggagccacg gttgatgaga gctttgttgt aggtggacca gttggtgatt 1020
ttgaactttt gctttgccac ggaacggtct gcgttgtcgg gaagatgcgt gatctgatcc 1080
ttcaactcag caaaagttcg atttattcaa caaagccgcc gtcccgtcaa gtcagcgtaa 1140
tgctctgcca gtgttacaac caattaacca attctgatta gaaaaactca tcgagcatca 1200
aatgaaactg caatttattc atatcaggat tatcaatacc atatttttga aaaagccgtt 1260
tctgtaatga aggagaaaac tcaccgaggc agttccatag gatggcaaga tcctggtatc 1320
ggtctgcgat tccgactcgt ccaacatcaa tacaacctat taatttcccc tcgtcaaaaa 1380
taaggttatc aagtgagaaa tcaccatgag tgacgactga atccggtgag aatggcaaaa 1440
gcttatgcat ttctttccag acttgttcaa caggccagcc attacgctcg tcatcaaaat 1500
cactcgcatc aaccaaaccg ttattcattc gtgattgcgc ctgagcgaga cgaaatacgc 1560
gatcgctgtt aaaaggacaa ttacaaacag gaatcgaatg caaccggcgc aggaacactg 1620
ccagcgcatc aacaatattt tcacctgaat caggatattc ttctaatacc tggaatgctg 1680
ttttcccggg gatcgcagtg gtgagtaacc atgcatcatc aggagtacgg ataaaatgct 1740
tgatggtcgg aagaggcata aattccgtca gccagtttag tctgaccatc tcatctgtaa 1800
catcattggc aacgctacct ttgccatgtt tcagaaacaa ctctggcgca tcgggcttcc 1860
catacaatcg atagattgtc gcacctgatt gcccgacatt atcgcgagcc catttatacc 1920
catataaatc agcatccatg ttggaattta atcgcggcct cgagcaagac gtttcccgtt 1980
gaatatggct cataacaccc cttgtattac tgtttatgta agcagacagt tttattgttc 2040
atgatgatat atttttatct tgtgcaatgt aacatcagag attttgagac acaacgtggc 2100
tttcagatcc gatatcctat cctgcaggtc gactcccgcg actcggcgtt cactttcgag 2160
ctattatcaa cgccggaata cgtcagaaac agccgtgccc cagggaccag aaagcctact 2220
ggtgagtatg ttctttcgtg tgatttttcc gaggatgaga acgacgataa cgagcacaac 2280
tcggagtcgg aggacacgct tattgcgttg aacgcagcca catcagcagg ctgtcaagac 2340
tgagtatggc cacagagctg gattctcggc ctcatactca agacgttagt aaactccgtc 2400
tgccagaaat tgctgacgag gatgtataat aatagatgaa ttacgaacaa ttgtagttca 2460
aaaaaattta gtaacaatat tgtctagatg acagatgtgc tgaaaccagt gaactccaat 2520
aaaccactca ccgctaccca agagaaacag atcagagtgc tagggccttg tttcagagta 2580
ctacaacgtt taccagaagc ttgagcaagt tctcaaacgc gggtttgtcg acatatgcac 2640
ccactaatag ggaacgtgag ctgggtttag accgtcgtga gacaggttag ttttacccta 2700
ctgatgaatg ttatcgcaat agtaattgaa cttagtacga gaggaaccgt tcattcagat 2760
aattggtttt tgcggctgtc tgatcaggca ttgccgcgaa gctaccatct gctggataat 2820
ggctgaacgc ctctaagtca gaatccatgc tagaaagcga tgatttcttg ccctcgcaca 2880
ttttagttgg atacgaataa ggcactctgt gtcgctgaac catagcaggc tggcaatggt 2940
gcttttaacg gaaaggtttt aagtgcttgc cggtggatag caatgtcatt atgcgcgagg 3000
ataaatcctt tgcatacgac ttaaatgtac aacggggtat tgtaagcagt agagtagcct 3060
tgttgttacg atctgctgag attaagcctc agttgtccga tttgtttgtg tttacacaac 3120
acaatctccc ctaagagata ttacttggtg gtagccgggt gtcttttaga ggagattttt 3180
tatatttttt tgagtagagg tcgtgcgtgg aacaattttg gatggttgtg tataaaattt 3240
tgaatcgaag agaccaatat tattttttaa ttacttatta ttttgtgttt tttttgtttt 3300
ttgatttaag ttatttaatt cagggataag ttggcttttt aatttttttg tttttatttt 3360
tttggtagca agcctttaat taaattgaat tttcgatgtg tagtggtgta aggatcttta 3420
tccaaaacat ttcggttgat attggccaat agaagtgtgt tgagctctga caaatgacag 3480
atattctgta ccatagtaag attcaaggta aatgagagaa aatgtatggt aattgatggc 3540
tgtcgtatga aaagtgagta cgatacgggc aactaagcta acaagagtag gcagaataga 3600
cagatattct gtgatgcaaa gtgtgtggca cacgtcctgt ttgtcatctg gcgctgagaa 3660
ggaaatttaa gcatagagat ggtggcagag ttgaaagagg tgctacaagg tgcctggaag 3720
agccggcaaa aaaagtggta gtggtaaagg atgaatgaag actttttgcg ccataccact 3780
gttgctgctc ttcctaaagg caggattaca agaagaagtc ggagggatta ggattggcga 3840
ccactcttct ctacgtgctg ggaggaaaaa aaagataggt gtggaagagg tgggcatata 3900
tatatagacg tttggataga caatggattg atgcagaacg cgacctcgag accgcgttgg 3960
actggaggga agggaaaaaa aaataataaa aaaaaaaaag attgcagcac ctgagtttcg 4020
cgtatggtct cccactacac tactcggtca ggctcttagc agcttaacta cagttgatcg 4080
gacgggaaac ggtgctttct gctagatatg gccgcaaccg aaagagtatg gaaacgagtg 4140
ggggatatga attgagaggg gggagaagta ctattcaact gttggttggt ggcagctatt 4200
gtagaacgaa atgcttaagt ataatatttt ttttttctcg gtaggtgaaa ttgtataaga 4260
gagaagacca ctgtagatga aggatgtact gatgtgaaac tgtatgagtg gtttgacgat 4320
tctacgtagg agaattaaaa agttggggaa attggaaatt agaggagaat ctcctgttga 4380
aaaatgaaga tcaagcatga aatgtatgaa tgccaatttg gagatcagca caacgtcatg 4440
ttaaagggga attgactgaa aagcgtagaa agtccatact ccagtgatga acttgtggtt 4500
tttcaagttt ctttaatttt ttcggttgtc gcgtagcagg gtggcacgaa gaaaaaattt 4560
cgtggtacca agaaatatgt cgggggaata atatttggag gcggtaggga attagaatcg 4620
aaatgaaaaa tataaaaagc tggaggaagg tgctaaaaaa aagccaatga ataattatgt 4680
aacttttgga aaaagttata ttagagagga aattttacgt gagagatgcg gatggacttt 4740
catgcgaaag cataaaagaa gatttgaaaa ctgaatgtga agaagcgaaa gcttctgcgc 4800
gtttggggtt cgattttcga aagggagttc tgaaaagagc tcttcaaggc ctcgttgatt 4860
agtggagaga gtaaagttgt tatcgtcaga tacactttct ctcaaggcta attcaacatg 4920
ggtgatcttg ggcggtcaaa aaaaataatt tttgatggtc tgagtagcct gaacagtctc 4980
ataccaaatt tctaattatt tttgtgtgtg agcactgatg gatttagtgg attactagcc 5040
tatggcaaga attcggacca caatccaaat aaagaaagtg catggaagaa gtaatcaaat 5100
aatttttaca tagcaagcaa caatagattt atttatcatg gcagccaagt ttgaaacacg 5160
aaagcgcgta caataataat gacgtatgtt gaactttttt tctccttaac tataaaaatc 5220
agttaagccg taaatatgta gatgaggccg tgctcagtcc tgctcctcgg ccacgaagtg 5280
cacgcagttg ccggccgggt cgcgcagggc gaactcccgc ccccacggct gctcgccgat 5340
ctcggtcatg gccggcccgg aggcgtcccg gaagttcgtg gacacgacct ccgaccactc 5400
ggcgtacagc tcgtccaggc cgcgcaccca cacccaggcc agggtgttgt ccggcaccac 5460
ctggtcctgg accgcgctga tgaacagggt cacgtcgtcc cggaccacac cggcgaagtc 5520
gtcctccacg aagtcccggg agaacccgag ccggtcggtc cagaactcga ccgctccggc 5580
gacgtcgcgc gcggtgagca ccggaacggc actggtcaac ttggccatat tgtttctata 5640
ttatctttgt actaaagagc aattgataat gtgcgagaaa aactggtcct tatatgccgt 5700
ttgcagcact ccctcccgaa ctttacgaaa agtcgtgcgc cacctgattt tcatcacgcc 5760
aaaaacctac acgtatgact actccgggcc agtgttcacc acgagctata tagtgttaat 5820
taattacctt attggttagc tctgcatgta agggtggtgt gagccgggaa ttgggtctac 5880
tctagcgttc agtaaggtga tataaagctc tgtatagcca gaagtggaca tcacccaaca 5940
aggcgtctcg gggacttgcc tgtccgtgca aggttgttcc atggaagctc taccgccgga 6000
gcggcccaaa ggacaataag aagtgctaca ccacctccgc agaggacaca ggcttaaaac 6060
cctctttctc ggtttcggga ccggttcccg gagattgtct ttaccccacg caccgtgctg 6120
gagccatagc agttgttgca actttgcgag ttgtcacctt ttcctccgtg gcccgcctct 6180
tttctggtgc acggatgtag tctagaccaa 6210
<210> 7
<211> 30
<212> DNA
<213> Artificial
<220>
<223> primer1
<400> 7
gaagatctta cggttatcca cagaatcagg 30
<210> 8
<211> 30
<212> DNA
<213> Artificial
<220>
<223> primer2
<400> 8
ggggtaccta agcattggta actgtcagac 30
<210> 9
<211> 33
<212> DNA
<213> Artificial
<220>
<223> primer3
<400> 9
gaagatctga aagccacgtt gtgtctcaaa atc 33
<210> 10
<211> 30
<212> DNA
<213> Artificial
<220>
<223> primer4
<400> 10
ggggtacccc tcgtgaagaa ggtgttgctg 30
<210> 11
<211> 51
<212> DNA
<213> Artificial
<220>
<223> primer5
<400> 11
gaagatctaa ggaaaaaagc ggccgcgttg gtctagacta catccgtgca c 51
<210> 12
<211> 24
<212> DNA
<213> Artificial
<220>
<223> primer6
<400> 12
attgtttcta tattatcttt gtac 24
<210> 13
<211> 25
<212> DNA
<213> Artificial
<220>
<223> primer7
<400> 13
gcacggcctc atctacatat ttacg 25
<210> 14
<211> 59
<212> DNA
<213> Artificial
<220>
<223> primer8
<400> 14
cgggatccga tatcctatcc tgcagaaaag aattcggacc acaatccaaa taaagaaag 59
<210> 15
<211> 45
<212> DNA
<213> Artificial
<220>
<223> primer9
<400> 15
tagtacaaag ataatataga aacaatatgg ccaagttgac cagtg 45
<210> 16
<211> 41
<212> DNA
<213> Artificial
<220>
<223> primer10
<400> 16
taaatatgta gatgaggccg tgctcagtcc tgctcctcgg c 41
<210> 17
<211> 40
<212> DNA
<213> Artificial
<220>
<223> primer11
<400> 17
aaaactgcag gtcgactccc gcgactcggc gttcactttc 40
<210> 18
<211> 59
<212> DNA
<213> Artificial
<220>
<223> primer12
<400> 18
ggaattctag ggagctccca attccatatg tcgacaaacc cgcgtttgag aacttgctc 59
<210> 19
<211> 37
<212> DNA
<213> Artificial
<220>
<223> primer13
<400> 19
ggaattccat atggggttta gaccgtcgtg agacagg 37
<210> 20
<211> 27
<212> DNA
<213> Artificial
<220>
<223> primer14
<400> 20
ggaattcttg ccataggcta gtaatcc 27
<210> 21
<211> 41
<212> DNA
<213> Artificial
<220>
<223> primer15
<400> 21
aaggaaaaaa gcggccgcaa cgatctcctc gagctgctcg c 41
<210> 22
<211> 27
<212> DNA
<213> Artificial
<220>
<223> primer16
<400> 22
tttgtttttg tactttagat tgatgtc 27
<210> 23
<211> 23
<212> DNA
<213> Artificial
<220>
<223> primer17
<400> 23
ggagacgtgg aaggacatac cgc 23
<210> 24
<211> 30
<212> DNA
<213> Artificial
<220>
<223> primer18
<400> 24
gaagatctca atctccggaa tggtgatctg 30
<210> 25
<211> 50
<212> DNA
<213> Artificial
<220>
<223> primer19
<400> 25
catcaatcta aagtacaaaa acaaaatggc tttgtggcgg cctagtgaca 50
<210> 26
<211> 48
<212> DNA
<213> Artificial
<220>
<223> primer20
<400> 26
gcggtatgtc cttccacgtc tccttacttc ctggcacgta cacgcaca 48
<210> 27
<211> 50
<212> DNA
<213> Artificial
<220>
<223> primer21
<400> 27
catcaatcta aagtacaaaa acaaaatggc tttgtggcgg cctagtgaca 50
<210> 28
<211> 48
<212> DNA
<213> Artificial
<220>
<223> primer22
<400> 28
gcggtatgtc cttccacgtc tccttacttc ctggcacgta cacgcaca 48
<210> 29
<211> 50
<212> DNA
<213> Artificial
<220>
<223> primer23
<400> 29
catcaatcta aagtacaaaa acaaaatggc tttgtggaga ccttctgaca 50
<210> 30
<211> 48
<212> DNA
<213> Artificial
<220>
<223> primer24
<400> 30
gcggtatgtc cttccacgtc tccttacttt ctagctctaa ctctaact 48
<210> 31
<211> 50
<212> DNA
<213> Artificial
<220>
<223> primer25
<400> 31
catcaatcta aagtacaaaa acaaaatggc tttgtggaga ccatcagaca 50
<210> 32
<211> 48
<212> DNA
<213> Artificial
<220>
<223> primer26
<400> 32
gcggtatgtc cttccacgtc tccttacttg cgagctctga ccctcact 48
<210> 33
<211> 38
<212> DNA
<213> Artificial
<220>
<223> primer27
<400> 33
ataagaatgc ggccgcggat ccaggaagcg caacgacg 38
<210> 34
<211> 47
<212> DNA
<213> Artificial
<220>
<223> primer28
<400> 34
tgtctgatgg tctccacaaa gccatgattt gattgatgaa ggcagag 47
<210> 35
<211> 25
<212> DNA
<213> Artificial
<220>
<223> primer29
<400> 35
atggctttgt ggagaccatc agaca 25
<210> 36
<211> 30
<212> DNA
<213> Artificial
<220>
<223> primer30
<400> 36
gaagatctca atctccggaa tggtgatctg 30
<210> 37
<211> 25
<212> DNA
<213> Artificial
<220>
<223> primer31
<400> 37
cgtagtactt gttcgcgtcg ctgta 25
<210> 38
<211> 25
<212> DNA
<213> Artificial
<220>
<223> primer32
<400> 38
gcagtggacg acctcatggt aaact 25
<210> 39
<211> 25
<212> DNA
<213> Artificial
<220>
<223> primer33
<400> 39
gctggtggag gtaacaaaca ggaca 25
<210> 40
<211> 25
<212> DNA
<213> Artificial
<220>
<223> primer34
<400> 40
gcaacgtaga gaaatccatc gcacc 25
<210> 41
<211> 35
<212> DNA
<213> Artificial
<220>
<223> primer35
<400> 41
ggaattccat atggctttgt ggagaccttc tgaca 35
<210> 42
<211> 31
<212> DNA
<213> Artificial
<220>
<223> primer36
<400> 42
ccgctcgagc tttctagctc taactctaac t 31
Claims (16)
1. a kind of method for the recombination Hansenula yeast cell for generating expression HPV 18 L1 (HPV18 L1) albumen,
It comprises the steps of:
A) by the way that the nucleotide for the coding HPV18 L1 albumen operably connecting with MOX promoter and MOX terminator will be included
The exogenous polynucleotide insetion sequence of sequence is shown in the carrier of SEQ ID NO:6 to construct expression construct;
B) Hansenula yeast cell is converted with the expression construct obtained in step a);With
C) the Hansenula yeast cell obtained in step b) is screened with Zeocin and G418, obtains and contains the external source multicore
The recombination Hansenula yeast cell of thuja acid.
2. the method for claim 1 wherein the amino acid sequences of the HPV18 L1 albumen to be shown in SEQ ID NO:1.
3. method for claim 2, wherein the nucleotides sequence of the coding HPV18 L1 albumen is shown in SEQ ID NO:5.
4. the method for claim 1 wherein convert Hansenula yeast cell by electroporation in step b).
5. the method for claim 1 wherein the Hansenula yeast cell in step b) is ATCC26012 Hansenula yeast cell.
6. the method for claim 1 wherein the G418 of the Zeocin and 10mg/ml that use 0.25mg/ml in step c) to step b)
The Hansenula yeast cell of middle acquisition is screened.
7. the method for claim 1 wherein screenings described in step c) to include
C1) the Hansenula yeast cell obtained in step b) is coated in the YPD plate of the Zeocin containing 0.25mg/ml, in 37 DEG C
It is inverted culture 3-5 days;
C2) picking is inoculated in 5ml containing 0.25mg/ml in the single colonie grown on the YPD plate of the Zeocin containing 0.25mg/ml
In the YPD fluid nutrient medium of Zeocin, in 37 DEG C, 200rpm shaking table culture 24-36 hours, until OD value is up to after 50, with 1: 1000
Ratio transfer in the YPD fluid nutrient medium of 5ml Zeocin containing 0.25mg/ml, culture to OD value is up to after 50, then with 1:
1000 ratio is transferred in the YPD fluid nutrient medium of 5ml Zeocin containing 0.25mg/ml, continuous to pass 10 times;
C3) the recombination expressed by Hansenula yeast bacterial strain access 5ml for reaching 10 times is free of to the YPD fluid nutrient medium of Zeocin resistance
In, in 37 DEG C, 200rpm shaking table culture to OD value up to after 50, transferred in 5ml YPD fluid nutrient medium with 1: 1000 ratio,
It is continuously passed 5 times in the YPD fluid nutrient medium without Zeocin resistance;With
C4) product of acquisition is coated on to the YPD plate of the G418 containing 10mg/ml, cultivated 2-3 days in 32 DEG C of inversions, picking growth
Vigorous single colonie carries out copy number detection.
8. the method for any one of claim 1-7, wherein the recombination Hansenula yeast cell contains the external source of multicopy
Polynucleotides.
9. method for claim 8, wherein the recombination Hansenula yeast cell contains the external source multicore that copy number is greater than 30
Thuja acid.
10. a kind of recombination Hansenula yeast cell of any one of -9 method generation according to claim 1.
11. a kind of method for generating HPV18 L1 albumen, comprising the following steps:
I) the recombination Hansenula yeast cell of claim 10 is cultivated under conditions of being suitable for the HPV18 L1 protein expression;
Ii it) is recycled from culture and purifies the HPV18 L1 albumen.
12. the method for claim 11 further includes the steps that carrying out purified HPV18 L1 albumen depolymerization and meet again.
13. the HPV18 L1 albumen that 1 or 12 method generates according to claim 1 is in preparation for preventing the epidemic disease of HPV18 infection
Purposes in seedling.
14. encoding the polynucleotides of HPV18 L1 albumen, it includes nucleotide sequences shown in SEQ ID NO:5.
15. a kind of expression construct is shown in SEQ by the way that the nucleotide sequence for encoding HPV18 L1 albumen is inserted into sequence
It is obtained in the expression vector pRMHP2.1 of ID NO:6.
16. a kind of expression vector, it includes nucleotide sequences shown in SEQ ID NO:6.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811381504.7A CN109321592A (en) | 2012-01-21 | 2012-01-21 | The method for generating HPV18 L1 albumen with expressed by Hansenula yeast system |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210021524.XA CN103215302B (en) | 2012-01-21 | 2012-01-21 | The method for generating HPV18 L1 albumen with expressed by Hansenula yeast system |
CN201811381504.7A CN109321592A (en) | 2012-01-21 | 2012-01-21 | The method for generating HPV18 L1 albumen with expressed by Hansenula yeast system |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210021524.XA Division CN103215302B (en) | 2012-01-21 | 2012-01-21 | The method for generating HPV18 L1 albumen with expressed by Hansenula yeast system |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109321592A true CN109321592A (en) | 2019-02-12 |
Family
ID=48813457
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811381504.7A Pending CN109321592A (en) | 2012-01-21 | 2012-01-21 | The method for generating HPV18 L1 albumen with expressed by Hansenula yeast system |
CN201210021524.XA Active CN103215302B (en) | 2012-01-21 | 2012-01-21 | The method for generating HPV18 L1 albumen with expressed by Hansenula yeast system |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210021524.XA Active CN103215302B (en) | 2012-01-21 | 2012-01-21 | The method for generating HPV18 L1 albumen with expressed by Hansenula yeast system |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN109321592A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113073105A (en) * | 2021-03-23 | 2021-07-06 | 重庆博唯佰泰生物制药有限公司 | Polynucleotide sequence for expressing HPV56L1, expression vector, host cell and application thereof |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104480131A (en) * | 2014-12-31 | 2015-04-01 | 中国医学科学院医学生物学研究所 | Construction and application of universal carrier for performing heterologous protein expression on pichia pastoris and hansenula polymorpha |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1152935A (en) * | 1994-05-16 | 1997-06-25 | 麦克公司 | Papillomavirus vaccines |
WO2004084831A2 (en) * | 2003-03-24 | 2004-10-07 | Merck & Co. Inc. | Optimized expression of hpv 31 l1 in yeast |
CN101487010A (en) * | 2008-01-15 | 2009-07-22 | 上海泽润生物科技有限公司 | Method for preparing vaccine for anti-HPV 18 infection by pichia yeast expression system |
CN101518647A (en) * | 2008-02-29 | 2009-09-02 | 江阴艾托金生物技术有限公司 | Human papilloma virus preventative vaccine, construction method and application |
US20110086402A1 (en) * | 2008-05-30 | 2011-04-14 | Charles Abbas | Engineering of xylose reductase and overexpression of xylitol dehydrogenase and xylulokinase improves xylose alcoholic fermentation in the thermotolerant yeast hansenula polymorpha |
CN102181426A (en) * | 2010-09-21 | 2011-09-14 | 大连雅立峰生物制药有限公司 | Expression and application of human papilloma virus type16 and 18 L1 protein in yeast |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY140664A (en) * | 2003-09-29 | 2010-01-15 | Merck Sharp & Dohme | Optimized expression of hpv 45 l1 in yeast |
-
2012
- 2012-01-21 CN CN201811381504.7A patent/CN109321592A/en active Pending
- 2012-01-21 CN CN201210021524.XA patent/CN103215302B/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1152935A (en) * | 1994-05-16 | 1997-06-25 | 麦克公司 | Papillomavirus vaccines |
WO2004084831A2 (en) * | 2003-03-24 | 2004-10-07 | Merck & Co. Inc. | Optimized expression of hpv 31 l1 in yeast |
CN101487010A (en) * | 2008-01-15 | 2009-07-22 | 上海泽润生物科技有限公司 | Method for preparing vaccine for anti-HPV 18 infection by pichia yeast expression system |
CN101518647A (en) * | 2008-02-29 | 2009-09-02 | 江阴艾托金生物技术有限公司 | Human papilloma virus preventative vaccine, construction method and application |
US20110086402A1 (en) * | 2008-05-30 | 2011-04-14 | Charles Abbas | Engineering of xylose reductase and overexpression of xylitol dehydrogenase and xylulokinase improves xylose alcoholic fermentation in the thermotolerant yeast hansenula polymorpha |
CN102181426A (en) * | 2010-09-21 | 2011-09-14 | 大连雅立峰生物制药有限公司 | Expression and application of human papilloma virus type16 and 18 L1 protein in yeast |
Non-Patent Citations (3)
Title |
---|
TENDULKAR,S.R.等: "ACU01871.1", 《GENBANK》 * |
李巍巍等: "人乳头瘤病毒16亚型L1蛋白在多形汉逊酵母中的优化表达", 《生物工程学报》 * |
陈凤菊等: "多形汉逊酵母外源基因表达系统", 《生物工程学报》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113073105A (en) * | 2021-03-23 | 2021-07-06 | 重庆博唯佰泰生物制药有限公司 | Polynucleotide sequence for expressing HPV56L1, expression vector, host cell and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN103215302B (en) | 2019-01-15 |
CN103215302A (en) | 2013-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Warzecha et al. | Oral immunogenicity of human papillomavirus-like particles expressed in potato | |
CN109776657B (en) | Recombinant norovirus VLP particles and methods of making and using | |
CN105056227B (en) | A kind of viroid particle VLP vaccines of foot-and-mouth disease virus resistant and preparation method thereof | |
CN107227311B (en) | Recombinant porcine parvovirus-like particle and preparation method and application thereof | |
CN104524564A (en) | Crucian herpes virus disease compound vaccine preparation, preparation method and application | |
CN105002146A (en) | RHVT (recombinant Herpesvirus of Turkey)-H9HA (H9 hemagglutinin) and construction method thereof | |
CN113061587A (en) | Antigen spectrum expanded O-type foot-and-mouth disease virus strain and construction method and application thereof | |
CN104745606A (en) | Coxsackie A16 type virus-like particles | |
CN110295190A (en) | The method for generating HPV45 L1 albumen with expressed by Hansenula yeast system | |
CN110592133A (en) | Method for producing HPV31L1 protein by using hansenula polymorpha expression system | |
Mariz et al. | Development of an IP‐Free Biotechnology Platform for Constitutive Production of HPV16 L1 Capsid Protein Using the Pichia pastoris PGK1 Promoter | |
CN109321592A (en) | The method for generating HPV18 L1 albumen with expressed by Hansenula yeast system | |
CN110484554B (en) | Method for producing HPV52L1 protein by Hansenula polymorpha expression system | |
CN110423774A (en) | The method for generating HPV58 L1 albumen with expressed by Hansenula yeast system | |
CN108624614A (en) | The method for generating HPV11 L1 albumen with expressed by Hansenula yeast system | |
CN110305807B (en) | Method for producing HPV33L1 protein by Hansenula polymorpha expression system | |
CN113336858B (en) | Rabbit hemorrhagic disease virus VP60 recombinant antigen with single site chimeric Pasteurella PlpE epitope, preparation and application thereof | |
CN101440372B (en) | 18 type human papilloma virus major capsid protein L1 gene | |
CN104164373B (en) | The method for generating HPV68L1 albumen with expressed by Hansenula yeast system | |
CN111154777B (en) | Recombinant human papilloma virus protein expression | |
CN103361377B (en) | The method that HPV6 L1 albumen is produced with expressed by Hansenula yeast system | |
RU2546240C1 (en) | RECOMBINANT STRAIN OF YEAST Hansenula polymorpha - PRODUCER OF MAJOR CAPSID PROTEIN L1 OF HUMAN PAPILLOMAVIRUS OF TYPE 56 | |
CN114107230B (en) | Bovine herpesvirus 1 type UL41 deletion strain and acquisition method thereof | |
CN109750050B (en) | Recombinant human papilloma virus 45 subtype protein expression | |
CN109750049B (en) | Recombinant human papillomavirus subtype 52 protein expression |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |